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ABSTRACT 
Aim 
There are known negative health outcomes associated with heart failure. 
Research has shown that illness perceptions, as conceptualised by the common-
sense model of illness, are associated with health outcomes in chronic illness. 
This systematic review examines the role of illness perceptions in heart failure 
(HF) outcomes.  
Methods 
A systematic literature search was conducted in April 2018 on the databases 
Medline, Embase, CINAHL, PsychINFO and Web of Science using key words and 
subject headings. Articles were assessed against eligibility criteria. Included 
studies were quality assessed using an adaption of the AXIS tool (Downes, 
Brennan, Williams, & Dean, 2016). Individual study results were compared using 
narrative synthesis. 
Results 
Two longitudinal and eight cross-sectional studies were included. The most 
commonly measured outcomes were anxiety and depression symptoms. Results 
across studies were inconsistent. There was limited preliminary support for a 
relationship between 1) perceived consequences of HF and illness outcomes and 
2) relationships between illness perceptions and anxiety and depression 
symptoms.  
Conclusions 
The differences in illness severity amongst participants, the application of 
outcome measures and the adjustment for covariates may partly account for the 
inconsistent results. The studies also lacked statistical power. Longitudinal 
designs and adjustment for co-variates are recommended for future studies. 
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INTRODUCTION 
What is heart failure? 
Heart failure (HF) occurs when the heart’s ability to circulate blood around the 
body becomes impaired.It affects approximately 900,000 people in the UK (NICE, 
2014). Average age at diagnosis is 77 years (Conrad et al., 2017). Prognosis 
following diagnosis is poor, with mortality at  36-38% within a year (Bleumink et 
al., 2004; Cowie et al., 2000). The New York Heart Association (NYHA) classifies 
severity from mild to severe: minimal symptoms are classified NYHA I; slight 
limitations to physical activity are classified NYHA II; symptoms whilst walking 
on the flat are classified NYHA III and patients whose functioning is severely 
limited are classified as NYHA IV (Mosterd & Hoes, 2007). 
Role of illness perceptions 
According to the common-sense model of illness perceptions, these are the 
representations individuals construct in response to a health threat (Leventhal, 
Meyer, & Nerenz, 1980). Following a diagnosis of heart failure, individuals will 
develop perceptions of what HF means to them, based on information obtained 
during diagnosis and from past experience (Leventhal, Phillips, & Burns, 2016; 
Weinman & Petrie, 1997). Research investigating the role of illness perceptions 
in acute and chronic health conditions has increased (Petrie, Jago, & Devcich, 
2007) and associations have been found with numerous outcomes, including 
psychological wellbeing and quality of life (Hagger & Orbell, 2003).  
Illness perceptions involve several key dimensions. Early research identified five 
dimensions: control/cure – the extent a person believes they can control or cure 
the illness; consequences – the anticipated outcomes of illness; identity – the 
symptoms perceived as part of the illness; timeline – the illness’s expected 
duration; and cause (Weinman, Petrie, Moss-Morris, & Horne, 1996). Later 
research divided the control/cure dimension into personal control and 
treatment control - the extent a person believes either themselves, or their 
treatment can control the illness. A cyclical timeline dimension was also 
incorporated and measured perceptions regarding the changeability of symptoms 
(Moss-Morris et al., 2002). Several questionnaires have been developed to 
measure these dimensions in accordance with the common sense model of 
10 
 
illness: the Illness Perceptions Questionnaire (IPQ) (Weinman et al., 1996); the 
Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2002) and 
the Brief Illness Perception Questionnaire (B-IPQ) (Broadbent, Petrie, Main, & 
Weinman, 2006). Differences in these questionnaires are detailed in Appendix 
1b. 
Illness perceptions in Heart Failure 
Heart failure patients’ negative outcomes include a higher prevalence of anxiety 
and depression than in the general population (Delville & McDougall, 2008; 
Konstam, Moser, & De Jong, 2005), poorer quality of life when compared to 
other chronic illnesses (Hobbs et al., 2002) and below optimal medical and 
lifestyle compliance (Van Der Wal et al., 2005). A meta-analytic study across a 
range of health conditions highlighted the importance of illness perceptions, 
particularly perceived consequences and symptoms, in determining illness 
outcomes (Hagger & Orbell, 2003). No studies with heart failure patients were 
included. Subsequent studies have investigated the role of illness perceptions in 
heart failure outcomes and there is some evidence for a role of illness 
perceptions in determining psychological distress (Hallas, Wray, Andreou, & 
Banner, 2011), quality of life (Mulligan et al., 2012) and medical adherence 
(Molloy et al., 2009). Interventions designed to target maladaptive illness 
perceptions have offered preliminary evidence for improved health outcomes 
(O'Rourke & Hampson, 1999; Petrie, Cameron, Ellis, Buick, & Weinman, 2002). A 
systematic review of the role of illness perceptions in heart failure outcomes 
therefore has the potential to inform clinical interventions. 
Aim 
This systematic review aims to provide a synthesis of the evidence concerning 
the relationships between illness perceptions, as defined by the common sense 
model of illness, and health outcomes in heart failure, such as psychological 
distress, health related quality of life and medication adherence.  
11 
 
 
METHODS 
Search strategy 
Scoping searches identified relevant studies and the indexing Medical Subject 
Headings (MeSH) and keywords. This informed the final syntax used to conduct 
the systematic literature search on the 12th April 2018 (Appendix 1c). The 
following databases were searched: Medline, Embase, CINAHL, PsychINFO and 
Web of Science. Results were limited to publications in English and from 1980, 
the year the common-sense model of illness was developed. The references of 
included studies were manually searched to identify additional relevant articles. 
Eligibility criteria 
Studies were included if: (1) participants were aged 18 years or over with a HF 
diagnosis; (2) illness perceptions were measured in line with the common sense 
model of illness using the IPQ, IPQ-R or B-IPQ; (3) outcomes were measured 
physiologically or with a standardised tool and (4) the relationship between 
illness perceptions and outcomes were reported. Studies were excluded if: (1) 
they utilised a qualitative or mixed methods design and (2) were non-peer 
reviewed (i.e. editorials, conference articles or dissertations). 
Data selection 
Data selection followed the process outlined in the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses flow diagram (Moher, Liberati, Tetzlaff, 
Altman 2009). Studies identified from the search strategy were screened and 
duplicates removed by the primary reviewer using reference management 
software. The primary reviewer screened the title and abstracts and excluded 
those not eligible. Where eligibility was unclear, the article was included for full 
text review. Potential articles were retrieved and independently assessed 
against the eligibility criteria by the primary reviewer. Those deemed suitable 
were included for data extraction and quality review. 
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Data extraction 
Key data from each article was extracted into a Microsoft Excel spreadsheet and 
used to complete the table of results. This included inclusion and exclusion 
criteria, study recruitment, sample size and characteristics, IPQ and outcome 
measurement, IPQ dimensions reported, statistical analysis, correlation and 
regression results. Where applicable, adjustment for confounding variables, time 
from baseline to follow-up and numbers lost to follow-up were also included. 
Quality assessment 
The quality of included studies was assessed using a modified version of the AXIS 
tool as developed and documented for cross-sectional studies by Downes et al. 
(2016) (Appendix 1d). It distinguishes between three elements of critical 
appraisal: quality of reporting, study design and bias. In line with 
recommendations, study-specific questions were incorporated (Sanderson, Tatt, 
& Higgins, 2007). Two questions covered attrition bias specific to cohort designs, 
two considered the fidelity of measurement and reporting of illness perceptions 
and one question considered adjustments for confounding variables. Irrelevant 
questions were removed (“Was the study design appropriate for the stated aims” 
and “Were the results internally consistent”). Two researchers independently 
rated included studies against the items related to quality of reporting, study 
design and bias. Items were marked yes, no, partially or don’t know. Inter-rater 
reliability was 81% (Appendix 1e). Disagreements between reviewers were 
resolved through discussion (for rating discrepancies and examples of discussed 
resolutions, see Appendix 1f). 
Data synthesis  
Narrative synthesis was used due to the heterogeneity of result. Recommended 
guidelines were followed (Popay et al., 2006). Results were synthesised by study 
design and by physiological or self-reported outcome measurement.  
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RESULTS 
Search results 
Figure 1 is a flowchart of the study selection process. Following removal of 
duplicates screening and the application of the eligibility criteria, 11 of the 
initial 4553 articles were reviewed. Following data extraction and quality 
assessment, one further article was excluded due to poor quality (Wierenga, 
2017) (see Appendix 1d). The remaining ten studies are reported in this review.  
14 
 
 
Figure 1 Participant flow diagram 
 
Study characteristics 
An overview of the ten included studies can be found in Error! Reference 
source not found.. The mean age of participants was 62.4. The average 
proportion of males was 75%. The sample is therefore younger and 
predominantly more male compared to the United Kingdom HF population 
(Conrad et al., 2017). Five studies were conducted in the UK, two in the USA, 
Articles identified through database searching 
(n = 4553) 
Articles after duplicates removed 
(n = 3551) 
Article title and abstracts 
screened 
(n = 3551) 
Full-text articles assessed for 
eligibility 
(n = 22) 
Articles included for data 
extraction and quality 
assessment 
(n = 11) 
Articles identified through 
manual search of articles 
reference lists 
(n = 0) 
Final articles included for 
narrative synthesis  
(n=10). 
Articles excluded 
(n = 3529) 
Full-text articles excluded,  
(n = 11) 
Validated IPQ measure not 
implemented, n=4; Population 
not HF specific, n= 2; Study 
design did not report 
relationship between IPQ and 
biopsychosocial outcomes, n= 
3; biopsychosocial outcome 
not measured numerically or 
with standardised tool, n=1; 
conference proceedings, n= 1. 
Articles excluded due to poor 
quality 
(n=1). 
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one in Italy, one in Ireland and one Europe wide. Studies included participants 
with different levels of illness severity, as measured by the New York Heart 
Association classification (NHYA) and only one study reported time with illness. 
Studies utilised prospective cohort (n=2) and cross-sectional (n=8) designs. The 
majority of studies used the IPQ-R (n=6), three used the B-IPQ and only one used 
the IPQ. The most commonly collected outcomes were anxiety and depression 
symptoms (n=6). Anxiety was measured using the Hospital Anxiety and 
Depression Scale (HADS) (n=5) and the Generalised Anxiety Disorder (GAD-7) 
(n=1). Depression was measured using the HADS (n=4), Patient Health 
Questionnaire (PHQ-9) (n=1) and Beck Depression Inventory (BDI) (n=1). 
Additional outcomes were self-care (n=3), quality of life (n=2) and medication 
adherence (n=2).  
Quality assessment 
Results from the quality assessment are presented in Appendix 1d. Assessment of 
study design found that two studies had samples with sufficient power 
(MacInnes, 2013; Turrise, 2016), one acknowledged an underpowered design 
(Goodman, Firouzi, Banya, Lau-Walker, & Cowie, 2013) and the remainder of 
studies did not report a sample size justification. Quality of reporting was 
mixed. Of concern, in half the papers methods were insufficiently described to 
allow study replication (Appendix 1d, Q10). In four papers inclusion and 
exclusion criteria were poorly defined (Appendix 1d, Q3). Risk of bias was 
considered across papers. Of the nine papers conducting statistical regression, 
only four adjusted for covariates (Appendix 1d, Q15). Eight of the ten studies 
failed to categorise non-responders (Appendix 1d, Q13). Six of the ten studies 
reported fewer IPQ dimensions than had been measured (Appendix 1d, Q21). 
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Table 1: Table of results 
Author , 
Year, 
Region 
Sample       N, 
age, % male,. 
HF type 
Response rate          
(1) baseline 
(2) follow up 
IPQ version 
and 
dimensions 
reported 
(n/n) 
Outcome 
measures 
Key findings Quality of 
reporting  
items 
“Yes” 
(n/n) 
Study 
design 
items 
“Yes” 
(n/n) 
Identified bias.  
Prospective Cohort Studies 
Goodman 
et al. 2013. 
UK 
88. Mean age 
70.5,  
70%. NYHA  II 
= 36 (40%), 
NYHA  III = 25 
(28%) 
,NYHA  I or IV 
= 9% 
(reported % 
did not add 
up to 100%).  
 
(1) 88/170 
(52%). 
(2) T2 6 
months: 21 
(24%) died; 17 
(19%) follow-
up 
questionnaires 
not returned.  
No significant 
differences in 
baseline 
characteristics 
IPQ-R (3/8) (1) Anxiety and 
Depression 
(HADS), (2) 
Self -Care 
(SCHFI), (3) 
Quality of Life 
(MLWHF). 
CONS: Increased perceptions of HF as having 
serious consequences were associated with 
decreased emotional** and physical** quality 
of life, and “probable” anxiety** and 
depression** at 6-month follow up. IC: 
Increased perceptions of understanding HF 
associated with less “probable” anxiety** and 
depression** and increased self-care 
confidence** at 6-month follow up.  
4/8  2/3 
(1) Sample size not justified 
(2) No comparison made 
between responders and 
non-responders at baseline. 
(3) Covariates not adjusted 
for 
Mulligan et 
al. 2012. 
UK 
210. Median 
age 72, 66%, 
ethnicity NR. 
NYHA  1 = 0, 
(1) 210/396 
(53%). 
Significantly 
younger, more 
IPQ (5/5 
reported 
but only 
where 
(1)  Anxiety 
and Depression 
(HADS), (2) 
Quality of Life 
Correlations NR. CONS: greater perceptions 
of HF as having serious consequences at 
baseline predicted less improvement in 
emotional QoL at 6 months**. Over 6 months: 
7/8 3/4 (1) 13% lost to follow up 
unexplained. (2) No 
comparison with 
participants at baseline. 
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NYHA  II = 19 
(11%), NYHA  
III = 64 (39%), 
NYHA IV = 83 
(50%). 
males, 
increased LV.  
(2)T2 6 
months: 
166/210 (21% 
lost: 17 (9%) 
died; 27 (13%) 
unexplained)  
significance 
found) 
(MLHF).  greater reduction in ID**, CONS**, C/C** 
associated with greater reduction in anxiety; 
greater reduction in ID** and CONS** 
associated with greater reduction in 
depression; greater reduction in ID** and 
CONS** associated with improved QoL. 
Cross Sectional Studies 
Cherrington 
et al, 2006. 
USA. 
22. Mean age 
51, gender 
NR. NYHA III = 
3 (13.6%),  
NYHA IV = 0 
(1) 22/34 
(64.7%) 
IPQ-R (0/8) Left 
ventricular 
dysfunction 
(LVEF) 
No illness perceptions dimensions correlated 
with Left ventricular dysfunction. 
8/8 3/4 (1) Small sample size (2) 
Non-responders 
uncategorised 
Giardini et 
al, 2017. 
Italy. 
120. Average 
age 57.2, 
83.3%. NYHA 
II = 22 
(18.3%), NYHA 
III = 89 
(74.2%), NYHA 
IV = 9 (7.5%). 
(1) 120/146 
(82.2%) 
B IPQ (8/8) (1) Depression 
(BDI II), (2) 
Anxiety 
(HADS). (3) 
Dispositional 
optimism 
(LOT-R). 
CONS: Increased perceptions of serious HF 
consequences correlated with decreased 
optimism**, increased depression ** and 
increased anxiety** symptoms. TC: Greater 
perceptions of treatment as effective in 
controlling HF correlated with increased 
optimism**. ID: Perceptions of HF as having 
more symptoms correlated with increased 
depression** and anxiety** symptoms and 
greater ID perceptions predicted more 
7/8 3/4 
(1) Non-responders 
uncategorised (2) Adjusted 
for age but no other 
covariates (3) Recruited 
from existing health 
programme. 
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depression symptoms**.  
Hallas et 
al, 2011. 
UK. 
 
146. Mean age 
48.6, 82% 
NYHA NR. 
(1) 146/284 
(51.4%) 
IPQ-R (8/8) (1) Anxiety and 
Depression 
(HADS), (2) 
Coping 
strategies 
(COPE), (3) 
QoL measured 
for additional 
hypothesis.  
Greater perceptions of HF symptoms as 
cyclical**, HF having serious consequences** 
and HF being outwith personal control* 
predicted greater depression scores. Greater 
perceptions of HF as having more symptoms** 
and symptoms as cyclical* predicted greater 
anxiety scores. CONS: Greater perceptions 
correlated with increased anxiety**, 
depression** and venting coping*. PC: greater 
perceptions correlated with decreased 
anxiety**, depression** and behavioural 
disengagement coping* TC: greater 
perceptions correlated with decreased 
anxiety**, depression**, behavioural 
disengagement coping**. ID: increased 
perceptions correlated with increased 
anxiety** and depression**. TLC: increased 
perceptions correlated with increased 
anxiety** and depression** IC decreased 
perceptions correlated with increased 
anxiety*, denial coping** and behavioural 
disengagement coping*. 
7/8 3/4 (1) Recruited from one 
hospital only 
MacInnes 
2013. UK. 
166. Mean age 
70.89, 74.1%. 
NYHA I = 
(1) 166/335. 
50.4%.  
IPQ R (5/8) (1) Self-Care  
(LAYHFQ). 
Self-care significantly correlated with 
CONS**, TC**, TLAC*, TLC**, IC**. CONS: 
greater perceptions that HF will have serious 
4/8 3/4 (1) Non-responders 
uncategorised (2) Self-care 
measure lacks concurrent 
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19.2%, NYHA 
II = 26%, NYHA 
III = 35.6%, 
NYHA IV = 
19.2%. 
consequences predicted greater total self-
care scores** 
validity, total score lacks 
clinical utility and subscales 
lack reliability (MacInnes, 
2011) (3) Socio-
demographics and illness 
severity not adjusted for. 
Molloy et 
al, 2009. 
UK. 
58. Mean age 
80.2, 57%. 
NYHA II = 34 
(59%), NYHA 
III = 24 (41%) 
(1) 58/229. 
(25%) (147 
chose not to 
participate, a 
further 24 not 
receiving 
relevant 
medication.) 
IPQ-R (2/8) (1) Medical 
adherence to 
angiotensin-
converting-
enzyme 
inhibitors 
(ACEI): defined 
as serum level 
<5U/L  
CONS: greater perceptions that HF will have 
serious consequences predicted less medical 
adherence*. TLAC: greater perceptions that 
HF will last a long time predicted less 
medical adherence* 19% of the variance 
explained by model.  
7/8 3/4 (1) Covariates not adjusted 
due to lack of statistical 
power.  
Morgan et 
al, 2014. 
IRELAND 
95. Mean age 
73.1, 81%. 
NYHA I = 
36.2%, NYHA 
II = 34.7%, 
NYHA III= 
26.3%,  NYHA 
IV = 6.3%. 
(1) 95/110. 
86% 
IPQ-R (8/8) (1) Anxiety and 
Depression 
(HADS) 
PC: Decreased perceptions of HF as 
personally controllable correlated with 
increased depression** and anxiety**. Illness 
perceptions explained a significant 
proportion of the variance in both anxiety 
(33.7%*) and depression (35.3%*), after 
sociodemographic and NYHA class accounted 
for. 
6/8 3/4  
Timmer-
mans et al, 
585. Average 
age  65, 79%. 
NR B-IPQ (0/8)  (1) Health 
Status (KCCQ) 
“Threatening illness perceptions” associated 
with poor health status*, anxiety*, negative 
7/8 3/4 (1) Threatening illness 
perceptions cut off (>46) 
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2017. 
EUROPE 
NYHA III= 194 
(33%). NYHA I, 
II and IV NR 
(2) Self-care 
(EHFScBS) (3) 
Anxiety 
symptoms 
(GAD-7). (4) 
Depressive 
symptoms 
(PHQ-9), (5) 
Type D 
personality 
(DS14), (6) 
implantable 
cardioverter 
defibrillator 
(ICD) related 
concerns 
(ICDC), (7) ICD 
acceptance 
(FPAS). 
affectivity*, poor device acceptance* and 
depression*. 
arbitrarily defined.  
Turrise, 
2016. USA 
97. Mean age 
68, 60%, 
NYHA class 
NR. 
NR B-IPQ (5/8) (1) Medication 
Adherence: 
The Medication 
Adherence 
Report Scale 
(21-25 high 
adherence,9-
20 low 
PC: Increased perceptions correlated with 
“low” medical adherence category* but not 
significantly predictive when medical beliefs 
adjusted for. TC: Decreased perceptions 
correlated with a hospital readmission within 
30 days of discharge**. Moderation analysis – 
ID: interacted with number of years living 
with HF to predict medication adherence - 
3/8 1/4 (1) Non-responders 
uncategorised (2) High and 
low medication adherence 
arbitrarily defined. (3) 
Small sample size in low 
medication adherence 
group. (4) Depression 
measure not stated (5) 
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adherence). 
(2) 30 day 
hospital re-
admission.  
direction NR. PC: interacted with depression 
to predict 30-day hospital readmission. 
Covariates not adjusted for. 
1Key: N; Number, NR; Not Reported, T1; time passed at first follow up. T2; time passed at second follow up; * = results significant at p <0.5 level; ** results significant 
at p < 0.01;  
IPQ dimensions: CONS; IPQ, IPQ-R and B-IPQ consequences subscale. C/C; IPQ control cure subscale, PC; IPQ-R and B-IPQ personal control subscale; TC; IPQ-R 
and B-IPQ treatment control subscale, ID; IPQ, IPQ-R and B-IPQ identity subscale, TL; IPQ and B-IPQ timeline subscale, TLAC; IPQ-R timeline acute/chronic 
subscale, TC; IPQ-R timeline cyclical subscale, IC; IPQ-R and B-IPQ illness coherence subscale. 
Measures: BDI II; Beck Depression Inventory II, COPE; The Cope Inventory, DS14; Type D Personality Scale; EHFScBS; European Heart Failure Self-care Behaviour 
Scale, FPAS; Florida Patient Acceptance Scale, GAD-7; Generalized Anxiety Disorder scale, Hospital Anxiety and Depression Scale, ICDC; ICD Patient Concerns 
questionnaire, KCCQ; Kansas City Cardiomyopathy Questionnaire, LAYHFQ; Looking  After  Yourself  with  Heart  Failure  Questionnaire, LOT-R; Life Orientation 
Test-Revised; MLHF; Minnesota Living with Heart Failure Questionnaire, PHQ-9; Patient Health Questionnaire, SCHFI; Self-Care Heart Failure Index, WHOQOL; 
World Health Organisation Quality of Life Brief Assessment. 
Narrative Synthesis 
Prospective cohort studies (n=2) 
Self-report measures:  
I. Anxiety and depression:  
Two studies measured anxiety and depression (Goodman et al., 2013; Mulligan et 
al., 2012). Table 1 shows that participants were similarly aged. Their HADS 
scores were categorised into borderline and probable anxiety or depression 
(scores of 8-11 and >11 respectively). As seen in table 1, when baseline 
covariates were adjusted for, perceived consequences and perceived 
understanding (coherence) were not significantly associated with anxiety and 
depression at follow up (Mulligan et al., 2012). In contrast, Goodman et al. 
(2013) did find significant associations with anxiety and depression (Table 1). 
However, Goodman et al failed to adjust for covariates. Mulligan et al. (2012) 
explored changes in illness perceptions over six months and found that 
reductions in perceived consequences and perceived symptoms of HF predicted a 
significant reduction in participants with clinically significant anxiety and 
depression at follow up (Table 1). 
II. Quality of life (QoL): 
Goodman et al. (2013) and Mulligan et al. (2012) explored the relationship 
between illness perceptions and quality of life using the Minnesota Living with 
Heart Failure Questionnaire. As seen in table 1, both studies produced consistent 
findings that greater perceived consequences of HF at baseline were 
significantly associated with poorer quality of life at follow-up. Mulligan et al. 
(2012) explored changes in illness perceptions over six months and found that 
reductions in perceived consequences and perceived symptoms of HF predicted 
significant increases in quality of life scores at follow up. 
III. Other: 
Goodman et al. (2013) found a significant association between increased 
perceived understanding (coherence) of HF and increased self-care confidence. 
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However, these results should be interpreted with caution as covariates were 
not adjusted for and the construct validity of the self-care measure had not 
been confirmed by factor analysis (Riegel et al., 2004; Yu, Lee, Thompson, Woo, 
& Leung, 2010). 
Cross sectional studies (n=7) 
Physiological measures: 
Cherrington, Lawson & Clark (2006) explored whether HF patients’ illness 
perceptions correlated with the percentage of blood pumped out of the heart’s 
left ventricle (LVEF). As seen in table 1, no significant correlations were found. 
This may in part be due to the small sample size (n=22); equally, the paper 
lacked a theoretical rational for the role of illness perceptions in LVEF. 
Molloy et al. (2009) measured HF patients’ angiotensin-converting-enzyme serum 
levels as a marker of medical adherence. Greater perceived consequences and 
greater perceptions of HF duration predicted significantly poorer medical 
adherence (Table 1). The small sample size (n=58), however meant covariates 
could not be adjusted for in a multivariate regression. The low response rate 
(25%) was also concerning as it called into question the generalisability of the 
findings. 
Self-report measures  
I. Anxiety and depression: 
Four papers measured anxiety and depression symptoms (Table 1). Of these, 
three papers explored illness perception dimensions (Giardini et al., 2017; Hallas 
et al., 2011; Morgan, Villiers-Tuthill, Barker, & McGee, 2014) whilst one paper 
looked at a total illness perception score (Timmermans, Versteeg, Meine, 
Pedersen, & Denollet, 2017). Relationships with illness perceptions were 
inconsistent. All studies were conducted in countries in Europe (Table 1).  
Two of the three studies investigating illness perception dimensions found 
significant positive correlations between perceived consequences of HF and 
number of symptoms (Giardini et al., 2017; Hallas et al., 2011) and lower 
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perceived personal control (Hallas et al., 2011; Morgan et al., 2014) (Table 1). 
All three studies conducted statistical regression. Hallas et al. (2011) found 
perceived consequences, personal control and cyclical symptoms were 
significantly associated with anxiety and depression whilst Giardini et al. (2017) 
found significant associations only with illness identity (symptoms). In contrast, 
Morgan et al. (2014) found no significant associations between illness perception 
dimensions and anxiety or depression (Table 1). However, Morgan et al. did find 
that total scores on the IPQ-R accounted for significant variance in anxiety and 
depression (Table 1). This suggests that overall illness perceptions contributed to 
anxiety and depression outcomes. All studies measured anxiety and depression 
as continuous variables. The lack of consistent findings across these studies may 
be due to the differences in ages and illness severity of the participants. For 
example, as shown in Table 1, the participants in Morgan et al’s study were 
significantly older.  
The fourth paper (Timmermans et al., 2017) categorised participants’ total B-
IPQ score into “threatening” or “non-threatening” illness perceptions. 
Threatening perceptions were determined by a cut off score of forty-three or 
above. Table 1 shows that threatening illness perceptions were significantly 
associated with presence of anxiety or depression, determined by a score of 10 
or above on the GAD-7 or PHQ-9. Whilst higher B-IPQ scores may be indicative of 
more threatening illness perceptions (Broadbent et al., 2006), a cut-off score 
has not been developed through research evidence, jeopardising ecological 
validity. Therefore these results should be interpreted cautiously. 
II. Self-care: 
MacInnes (2013) and Timmermans et al. (2017) examined the relationship 
between illness perceptions and self-care. MacInnes (2013) found significant 
correlations between self-care and many IPQ dimensions (Table 1). Whether self-
care scores indicated improved or poorer quality of life was not reported, 
making interpretation of the results difficult. Equally, the development of the 
self-care tool lacks validity (Table 1; MacInnes, 2011) thus ecological validity is a 
concern. Timmermans et al. (2017) found no relationships between threatening 
illness perceptions and self-care (Table 1); however, as already discussed, the 
ecological validity of this category is questionable.   
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III. Medication adherence: 
Turrise (2016) found that illness perceptions were not significantly related to 
self-reported medication adherence (Table 1). However, the definition of high 
and low medication adherence appeared to be arbitrary and may lack face 
validity or sensitivity. Therefore, the results should be treated with caution. A 
more objective measure may have yielded different results (Molloy et al., 2009).  
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DISCUSSION 
A systematic review was conducted to explore the relationship between illness 
perceptions and outcomes in adult patients with HF. Results were inconsistent 
and risk of bias noteworthy. Thus only limited conclusions can be drawn. Two 
preliminary patterns emerged. First, perceptions of greater negative 
consequences of HF were related to worse outcomes including: increased anxiety 
and depression symptoms; reduced quality of life; and reduced medical 
adherence. These findings are in line with a previous meta-analysis which found 
perceptions of negative consequences were associated with worse psychosocial 
functioning (Hagger & Orbell, 2003). Second, there was some preliminary 
evidence for a relationship between illness perceptions and symptoms of anxiety 
and depression. These relationships were found in both longitudinal and cross-
sectional designs. Perceived consequences, symptoms (identity), personal 
control and total illness perception were associated with anxiety and depression 
symptoms in several studies (Giardini et al., 2017; Goodman et al., 2013; Hallas 
et al., 2011; Morgan et al., 2014; Mulligan et al., 2012; Timmermans et al., 
2017). Whilst evidence is limited and further research is required, it points to 
the role of illness perceptions in psychological distress in heart failure. This is in 
line with findings from patients with other chronic illness such as: cancer 
(Richardson, Schüz, Sanderson, Scott, & Schüz, 2017); coronary heart disease 
(Foxwell, Morley, & Frizelle, 2013); irritable bowel syndrome (Rutter & Rutter, 
2007); and chronic fatigue syndrome (Edwards, Suresh, Lynch, Clarkson, & 
Stanley, 2001). 
Strengths/limitations of included studies 
This review identified a limited number of studies, which varied in the types of 
illness outcome measured. As the majority of studies were cross-sectional, 
conclusions regarding causality or predictive relationships are precluded. 
Response bias across studies is a concern as the majority of studies did not 
categorise non-responders and some papers did not report numbers eligible for 
the study. More than half the included studies either did not, or only partially, 
adjusted for confounding variables including socio-demographic variables, illness 
severity and duration of illness. Therefore, these results should be interpreted 
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with caution as validity may have been jeopardised. Moreover some studies 
adopted arbitrary cut-offs that were not validated for the outcome measures 
used.  
Of particular concern, six studies did not fully report all the IPQ dimensions they 
measured, reflecting a trend to focus on significant findings (Goodman et al., 
2013; MacInnes, 2013; Molloy et al., 2009; Mulligan et al., 2012; Turrise, 2016; 
Timmermans et al., 2017). Lastly, behaviour and coping are known to be 
mediators between illness perceptions and outcomes (Leventhal et al., 2016), 
yet these were not included in any of the study designs. Given the limited 
number and the variable quality of included studies, it is difficult to draw firm 
conclusions from the review findings.  
Theoretical implications 
The common-sense model of illness postulates interactive dynamics between a 
person’s perceptual and behavioural responses to an illness threat (Leventhal et 
al., 2016). What determines these responses and how they change over time are 
also relevant when exploring the common-sense model (Leventhal et al., 2016). 
The studies included in this review predominantly examined a person’s 
perceptual processes captured during a specific moment in time. Therefore, only 
partial components of the common-sense model were measured making it 
difficult to draw theoretical conclusions. The results found here may represent 
an oversimplification of a complex dynamic process (Leventhal et al., 2016). 
Recommendations for future research 
In general, future studies may benefit from seeking to measure illness 
perceptions as one element of a complex interactive process leading to health 
outcomes (Leventhal et al., 2016). Future studies should seek to measure the 
determinants of illness perceptions, such as communication with care givers and 
information from medical providers; perceptual changes over time; and how a 
patient plans for, commits to and adjusts their coping behaviour. It is likely a 
combination of these elements which determine health outcomes in heart failure 
and would provide the best evidence for informing clinical practice.   
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Future studies may benefit from carefully justifying the use of cut-off scores to 
determine categorical variables. It may be beneficial for future research to 
statistically adjust for differences in time since diagnosis to help control for 
psychological distress associated with a new diagnosis of heart failure or with 
the impact of advancing illness. 
Strengths/limitations of review process  
This review investigated HF patients’ illness-specific representations, as 
conceptualised and measured in accordance with common sense theory of illness 
(Leventhal et al., 1980). Incorporation of HF patients’ global health 
representations, as postulated in the health beliefs model (Rosenstock, Strecher, 
& Becker, 1988) and health locus of control model (Wallston, Strudler Wallston, 
& DeVellis, 1978), would have broadened the measures included. In doing so, a 
greater number of studies may have been included. However, this would have 
precluded theoretical conclusions based on the common-sense theory of illness.  
This review sought to explore the role of illness perceptions across any illness 
outcome in heart failure. The heterogeneity of the outcomes measured in the 
included studies makes it difficult to draw clear conclusions. It may be more 
helpful for future systematic reviews to focus on specific outcomes, such as 
psychological distress. Whilst an effort was made at full review stage to ensure 
validity and reliability of the self report tool was reported, limitations regarding 
the validity remained. This included use of cut scores not justified by research 
literature, the lack of rigorous methodology during tool development and scores 
lacking clinical utility. A future focus on narrower outcomes would allow an 
defined list of well developed and clinically utilised self report measures to be 
used for eligibility screening.  
There are several strengths of this review. Search terms were kept broad and 
references were checked in attempt to capture all available evidence. In doing 
so, the review has captured and synthesised the growing body of research into 
the illness perceptions of people with heart failure.  
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CONCLUSION 
In conclusion, this review is the first to synthesise the research evidence into 
illness perceptions and heart failure outcomes. The ten included studies 
measured a variety of outcomes. Results were inconsistent. There was 
preliminary evidence for a relationship between perceived consequences of HF 
and outcomes. Furthermore, relationships were found between numerous illness 
perceptions and anxiety and depression symptoms, albeit inconsistently. Illness 
perceptions may play a role in patients’ mental wellbeing and distress. It may 
therefore be beneficial for health care professionals to understand how patients 
understand their illness. Additionally, in line with the common-sense model of 
illness, future studies should seek to measure the interactive dynamics of coping 
behaviour perceptions and their determinants over time to best inform clinical 
practice.  
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PLAIN LANGUAGE SUMMARY 
Background 
Heart transplant is an operation to replace a failing heart with a healthy heart 
and involves waiting for a matching heart from a person who has recently died. 
This can be a long wait and may be very distressing for people. Very little 
research has been done looking at how people experience this wait.  
Aims 
This study aimed to explore people’s experiences whilst waiting for heart 
transplant. This may help to develop support for people in the future who are 
waiting for a heart transplant. 
Method and data analysis  
Seven men on the Scottish waiting list for heart transplant agreed to take part in 
individual interviews with the researcher. Interviews lasted between 50 and 80 
minutes. The way we explored people’s experiences was through a research 
method called Interpretative Phenomenological Analysis. It involved conducting 
and transcribing interviews and then interpreting what the participant said and 
why they may have said it. The researcher looked for patterns in what people 
had said and discussed these as ‘themes’. Themes were supported by participant 
quotes.  
Results  
Three major themes were discussed. The first theme was ‘threatened self 
identity’. Men felt that being ill challenged who they felt they were. The second 
theme was ‘uncertain life or death’. Life in the present and in the future, with 
or without a transplant, felt very uncertain for the men. Part of this included 
the knowledge that they could die either waiting, during or after transplant. The 
third theme was ‘complex coping’ and captured the nature of trying to cope in a 
very emotionally and physically challenging wait for heart transplant. 
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Conclusions 
These results provide valuable insights into individuals’ personal experience of 
waiting for transplant. This may help to design supports for transplant patients, 
including through Psychology. A key finding was that patients need to find 
meaning in waiting and certain psychological interventions appear likely to help 
with this. It is important that all health care professionals acknowledge that 
people make sense of their wait for transplant in a variety of ways. 
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ABSTRACT 
Background 
Heart transplant candidates may wait a considerable and usually indeterminable 
length of time for a donor heart, uncertain if they will live or die. Despite this, 
there appears to be little research exploring how people experience this wait.  
Method  
A qualitative design employed Interpretative Phenomenological Analysis. Male 
patients (n=7) on the routine waiting list for a heart transplant at an advanced 
heart failure service in Scotland participated in a semi-structured in-depth 
interview. 
Results  
Three major themes, each with inter-related sub-themes were produced from 
the data. 1) ‘Threatened self identity’: this theme covered the challenge posed 
to the mens’ identities as a consequence of illness and their wait for transplant. 
This included a ‘diminished self’ and an ‘unwanted ill self’. 2) ‘Uncertain life or 
death’: this theme concerned the continuing uncertainty men had to live and 
cope with, and included ‘contemplating dying’ and ‘the unknowns of transplant’. 
3) ‘Complex coping’: this theme covered the challenges of coping during the 
emotionally and physically challenging wait for transplant.  
Conclusions 
The importance of finding meaning in waiting is discussed in relation to the 
revised transactional model of stress and coping, and the implications for health 
care professionals are discussed. There is a need for health care professionals to 
appreciate the individual meaning patients ascribe to their experiences. 
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INTRODUCTION 
Waiting for heart transplant 
There is a shortage of donor hearts in Scotland, leading to long waiting times for 
a heart transplant (Scottish Government, 2013). Several months, or possibly 
years, may pass before a donor heart is identified. In the UK, median wait times 
are approximately three and a half years (NHS Blood and Transplant, 2017). The 
journey to transplant is complex; patients may have had an acute episode or a 
long history of poor cardiac health before receiving a diagnosis of heart failure 
and it is only when the heart failure is advanced that a transplant is considered 
(Bunzel, 2012). Illness severity determines individuals’ listing status as ‘super-
urgent’, ‘urgent’, or ‘routine’ and the likelihood of having to remain within 
hospital or wait at home. Candidate selection for transplant is not orderly and 
relies on multifarious considerations including: organ availability, a match of 
donor, presence of antibodies and recipient body size and blood type. 
Candidates have no influence over when, or if, they will receive a transplant and 
escalating health problems may either accelerate their listed position or 
compromise their candidacy for transplant (Bunzel, 2012). 
Research on waiting 
There is limited research focussed on patients’ wait for heart transplant. 
Existing research suggests that psychological distress is not uncommon, with 
patients scoring as mildly depressed or anxious on validated screening 
instruments (Deshields, McDonough, Mannen, & Miller, 1996). It is generally 
accepted that the wait for transplant is emotionally challenging with numerous 
stressors (Bunzel, 2012; Jalowiec, Grady, & White-Williams, 1994). The existing 
qualitative research is limited. No studies have recruited patients solely during 
the wait period, nor utilised a phenomenological approach to explore how 
patients might experience this. One qualitative study, which included 
participants post transplant, found that participants described a loss of their 
prior life, their autonomy and considered their own death and the death of the 
donor (Poole et al., 2016). Another qualitative study, which used a focus group 
and included patient’s relatives, explored opinions on interventions for the 
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waiting period. Participants referenced a pervasive wondering of “when” 
transplant would happen (Haugh & Salyer, 2007) however, due to the aims of the 
study, little other weight was given to detailing participants experiences.  
Aim 
No studies have focussed on the lived experience of heart transplant candidates 
from a phenomenological perspective. The aim of the present study was to gain 
an in-depth insight into heart transplant candidates’ lived experience of waiting 
for a heart transplant. 
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METHODS 
Design 
A qualitative design engaged an interpretative phenomenological approach (IPA). 
Participants took part in a semi-structured in-depth interviews.  
Ethics 
Ethical approval was received from the West of Scotland Research Ethics Service 
(Appendix 2b). Informed consent was taken by the first author (R.J) at the time 
of interview (Appendix 2c). Participants’ names and identifiable information 
were changed to preserve confidentiality.  
Recruitment 
Seven participants were recruited from a national advanced heart failure service 
in Scotland. Participants were included if they were: on the ‘routine’ list for 
transplant for at least three months, fluent in English, aged 18 or over and able 
to give informed consent, and excluded if they had a history of previous heart 
transplant or learning disability. Transplant co-ordinators identified eligible 
participants, informed them about the study and provided them with the study 
information sheet (Appendix 2d). Those interested consented to their contact 
details being passed on to the researcher, who then contacted them to arrange a 
suitable interview time. One interested participant cancelled their interview 
without offering a reason for doing so.  
Sample characteristics 
All participants were on the ‘routine’ waiting list and were living at home while 
waiting for their transplant. The participants were male and aged between 25 -
63. Length of wait at the time of interview varied between nine months to three 
years. Two of seven participants continued to work. Individual demographics are 
omitted due to risk of participant identification. 
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Data collection 
Interviews were carried out between September 2017 to April 2018. One 
interview was conducted with each participant by the primary researcher (R.J). 
Interviews took place in a non-medical hospital room and lasted between 50 -80 
minutes. They began with an open-ended question asking for participants’ 
experience of being told they needed a heart transplant. The interviewer then 
went onto ask the participants about their experience of waiting for a 
transplant. The interviewer tried to promote a dialogue and follow the 
participant’s story. Probing questions were used to encourage the participants to 
develop their accounts, such as “what did you mean by that?” and “what was 
that like for you?”. In line with the exploratory principles of IPA, this approach 
provided participants the opportunity to tell their story in a way that made 
sense to them. Areas explored in interviews were adapted as interviews 
progressed with an increasing focus on issues the participant raised. An 
interview schedule was constructed via consultation with a clinical psychologist 
at a heart transplant centre and was drawn from their knowledge of service user 
experience (Appendix 2e). It was used loosely to guide questions around certain 
areas when these had not arisen naturally. Interviews were recorded and 
transcribed verbatim, with exception of identifiable information which was 
deleted or changed.  
Analysis 
Data was analysed in accordance with the principles of Interpretative 
Phenomenological Analysis (IPA) (Smith, Flowers, & Larkin, 2009).Transcripts 
were read and annotated line-by-line, noting participants’ descriptions and use 
of language and the researcher’s ideas regarding the participant’s meaning 
(Appendix 2f). Recurrent patterns in individual transcripts were interpreted as 
emergent themes. Patterns across transcripts were noted as the analysis of 
transcripts progressed. These were further interpreted and developed through 
an iterative process, whereby patterns were clustered together and abstracted 
into broader interpreted themes such as “death” “uncertainty” or “identity”. To 
ensure an ideographic perspective, these were cross checked against individual 
transcripts and quotations from each participant for each theme were tabulated 
(Appendix 2g). Several iterative cycles commenced and continued into the 
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writing up phase before the major and subthemes presented in this paper were 
finalised. These were considered the ‘best fit’ to participants’ stories. The 
selected quotations were those thought to capture the essence of the theme or 
provided particular insights. An attempt was made to ensure all participants’ 
voices were represented. Analysis involved supervision with an experienced IPA 
researcher who read over transcripts, checked initial annotation, suggested 
alternative interpretations and provided feedback on quote selection. Face 
validity of the final model was confirmed by one participant (Appendix 2h) and a 
consultant clinical psychologist working with heart transplant candidates. 
Reflexivity 
The researcher (R.J.) had previously worked as an assistant psychologist in an 
advanced heart failure service. R.J. had gained knowledge of the complex 
processed involved in waiting for heart transplant and had heard first hand 
accounts of people’s experiences. This influenced the development of the 
research as R.J wanted to explore the challenges people faced during their wait 
for transplant.  A developmental journey took place in the course of research. 
R.J. realised the importance of holding an open mind to participants’ 
experiences, as opposed to interpreting their narratives as evidence of a 
challenging wait for transplant. R.J. was required to suspend “formulating” the 
participants’ emotional difficulties during interviews and initial analyses and 
fully engage with the participants’ narratives, what they meant and how they 
had made sense of their experiences.  R.J. realised that an important narrative 
was that of resilience and coping, as opposed to purely challenges and distress. 
R.J. kept a reflexive journal throughout the research to aid awareness of this 
interpretational process (Appendix 2i).  
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RESULTS 
Three major themes: 1) Threatened self identity; 2) Uncertain life or death; and 
3) Complex coping, and four interrelated subthemes were produced from the 
analyses of the interviews. These themes and subthemes are outlined in Table 2 
and described in depth in the following text, illustrated by participant quotes. 
The following notation is used when presenting quotes:  ".." indicates the person 
took a short pause, (pause) indicates a longer pause and […] indicates that a 
small portion of irrelevant/confidential text has been deleted. 
Table 2 Major Themes and Sub Themes 
Major theme Sub theme 
1) Threatened self identity A diminished self 
An unwanted ill self 
2) Uncertain life or death Contemplating dying 
The unknowns of transplant 
3) Complex coping 
 
1.Threatened self identity 
The men described the combination of illness and waiting for a heart transplant 
as a challenge to their self identity. This has been interpreted using two 
interrelated subthemes: 1) A diminished self and 2) an unwanted ill self. 
A diminished self:  
All men reported experiencing a reduction in valued aspects and roles from their 
lives from before illness and their wait for transplant. The use of language 
suggested that these losses had given rise to a diminished sense of themselves 
and their worth. Michael was advised by health care professionals to retire due 
to both ill health and in order to access the transplant waiting list. He explained 
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that stopping work had impacted on his family role and how he felt about 
himself:  
“it diminishes what you feel you’re worth .. when you're doing a job 
and you're working you know exactly where you are ..you've actually 
got a purpose […] the main purpose is providing for your family I 
suppose” (Michael).  
In the absence of his role to provide for his family, Michael described diminished 
self worth and appeared to feel lost. Many men alluded to a diminished self 
worth following reduced occupation and activity. Christopher, whose successful 
career in senior management had ended with his illness articulated this as a 
“loss of status” and appeared to experience a sense of worthlessness:  
“I've got nothing interesting to say.. cause I didn't do anything today 
(cries) .. that's very tough” (Christopher) 
Christopher was clearly distressed, possibly due to the stark contrast of his 
previous ‘working’ life and his present, reduced, existence.  The distress may be 
a regular occurrence for Christopher when his time contains limited occupation 
and activity.  
For Gregor, general reduced activity alongside the waiting list restrictions on 
holidays abroad, diminished his role as ‘father’ and his perceived ability to 
engage with his children:  
“you're only here once, you're going through a life you've got a young 
family […] your kids are only young once, you don't want to go 
through the majority of their life with you being the one that can't 
do activities with them” (Gregor)  
And later: 
“they’re the ones that suffer through it, through no fault of their 
own” (Gregor). 
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Gregor was acutely aware of lost opportunities with his children whilst were still 
young and there was a painful sense he believed he was letting his family down. 
When he stated that his children were not to blame there was a sense that he 
was blaming himself. 
An unwanted ill self 
Six men spoke of an ‘ill self’ discordant with who they felt they were. This arose 
from reduced freedom due to illness and the restrictions placed on their activity 
and diet as part of their wait for transplant. This ‘ill self’ seemed related to a 
fear of becoming lazy or a burden on others and was a source of distress. Peter 
stated that being inactive did not feel like his real self: 
“I don’t know why I’d be sitting ‘oh I got a heart problem I can’t be 
doing that’ sorta thing […] it’s just not me” (Peter) 
His sarcastic use of “oh” had connotations of a person making an unworthy 
excuse, as if his illness was not a valid reason for inactivity, possibly reflecting 
his broader belief that to be inactive is to be lazy. 
The threat of illness was apparent in Alec’s narrative. Unlike Peter, the threat of 
his ill self related to his family:  
“because of what I have .. it stops my family from doing what they 
want to do, so the guilt kicks in […] if I didn’t have this, everybody's 
else’s lives would move on” (Alec) 
Alec appeared to have a strong sense that his illness had made him a burden on 
his family. The “kick” of his “guilt” suggested that this was very painful for him.  
Ryan described his frustration at his inability to achieve the things he used to be 
able to: 
“you’re trying to do something that you can't do and you get 
frustrated and you just (sighs) I'm not a bad tempered person (laughs) 
I'm quite an easy going person” (Ryan) 
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Here, Ryan expresses ‘frustration’ at his loss of capacity. This lead him to 
identify with his bad tempered ‘ill’ self that contrasted with his usual “easy 
going” self. 
2. Uncertain life or death 
All men referred to the paradoxical nature of waiting for heart transplant. There 
was an acknowledgment that, whilst a transplant might cure them, the wait for 
the transplant posed numerous threats to their life and could result in death. 
This theme is discussed as two interrelated subthemes 1) contemplating dying 
and 2) the unknowns of transplant. 
Contemplating dying 
All men contemplated their death. Many stated that death was not feared but 
expressed concern regarding its impact on their families. Christopher was 
worried his wife would have to “come round and clean up the mess” when he 
referred to the possibility of dying in transplant. Peter wondered how his wife 
would cope and Gregor felt upset that his children would have to “live without a 
Dad”. Alec’s view that he was a burden on his family extended to his fear of 
dying in transplant, as he pointedly explained:  
“everyone dies I understand that but it goes back to the guilt […]..if I 
die, their lives .. I can’t even describe how they would cope” (Alec) 
Exhaustingly, he appeared to blame himself not only for his illness but for the 
possibility of dying during transplant. The guilt of being ill coupled with the guilt 
of being on the transplant list seemed to preoccupy him.  
Both Ryan and Andy imagined the benefits that could arise from their death. 
Andy spoke calmly of an optimal sudden death: 
“.. the heart attack will get you first [...] to me that's actually the 
best case scenario because its clean .. there's no waiting about in 
hospital waiting to die .. I imagine it to be quicker and cleaner to 
those you're leaving behind.. that way the wife gets the mortgage 
paid off, she’s gonna have a bit of money to go do things” (Andy) 
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He believed a good death to be one that was quick and clean and therefore least 
burdensome on his wife. Therefore, his conviction he would die from a quick 
heart attack may have provided comfort and helped him to cope emotionally. 
For Michael and Peter, comfort appeared to be gained through placing trust in 
another. As Michael illustrated: 
“I mean people do die but then you're going to die anyway .. it’s 
something people can't escape, nobody escapes it, it’s just .. that’s it 
so .. to me ah .. I put my hands in the trust of these Doctors and I do 
trust them ..” (Michael) 
His lack of words to explain what dying would mean might have been due to his 
wish to avoid this painful topic. He seemed unsettled and his rush to speak about 
his trust in Doctors suggested this was a method of coping.  
Peter did not trust the Doctors but instead placed his trust in God: 
“if I do die well I die you know .. obviously you don’t want to die, you 
want to die as late in life as possible and enjoy it .. but if that's what 
God wants .. then you'll be quite happy with that .. I suppose it 
comes down to faith and trust in God” (Peter) 
Peter revealed contradicting perspectives within his account. He simultaneously 
conveyed a desire for life yet stated he’d be “quite happy” should he not 
survive. His use of second person pronoun “you’ll” pointed to a personal 
distance from this conflict. He was perhaps both comforted by the thought of 
dying with faith in God yet saddened at the thought of his lost life. This 
dissonance appeared to account for his tension around these opposing emotions. 
The unknowns of transplant 
All the men talked about the difficulty of waiting for a transplant because of the 
uncertainty about when it might happen and what life with a transplant could 
mean. Peter and Ryan described how such thoughts dominated their waking 
lives: 
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“you wake up everyday thinking, is this the day? You go to bed 'oh 
well that's another day' and you wake up tomorrow .. is it gonna be 
today? And it’s a complete circle it just goes round and round and 
round and round” (Ryan) 
Ryan’s numerous repetitions of “round” gave a sense of exhaustion and 
conveyed the inescapable nature of his thoughts. For Gregor, the uncertainty of 
‘when’ caused him to fear his heart failure would progress and prevent him 
receiving a transplant: 
“you feel that the clock is ticking and my fear is that I end up I start 
to get ill and I become too ill that I can't get it” (Gregor) 
The passing of time seemed to dominate Gregor’s narrative. There was an 
apparent pressure of speech which, in itself, evoked the sense of a clock ticking. 
There was a sense that the passing of time represented reduced opportunity for 
transplant, for a new lease of life, and to resume his ‘father’ role. 
Many of the men were concerned with the uncertain outcome of their 
prospective transplant. Michael and Peter contemplated whether a transplant 
would permit a return to their previous, freer lifestyles or whether it would 
bring a fresh set of health challenges that would restrict their lives. Peter, who 
spoke of struggling to manage his “medical regimen” explained:  
“once heart transplant has been done you know they're telling you 
that er .. you’re gonna be on another set of pills and you have to 
keep a record of when you take them .. and they say you have to be 
really strict” (Peter) 
He appeared anxious about the “strict” medical adherence, perhaps as it 
represented continuation of the stress associated with his “medical regimen”, 
beyond transplant. Many of the men recalled the statistics of numbers surviving 
transplant and considered what this meant for their chance of survival. For 
some, this caused doubt as to whether the outcome would prove worthwhile. 
Alec and Christopher rehearsed the reasons to withdraw from the transplant 
process: 
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“is this heart transplant such a good idea after all […] it’s a very, 
very serious operation and the medication that comes after it is 
pretty horrible and you're going to have to have .. the strength and 
self belief to see it through .. in full knowledge that you’re quite 
possibly working against percentages because half the people aren't 
alive in five years time” (Christopher) 
Christopher had a negative view of transplant. He appeared concerned that he’d 
fail to muster the energy and courage to live with a transplanted heart, knowing 
that life would be limited. 
3. Complex coping 
All mens’ narratives provided insight into their nuanced attempts to cope and 
find meaning in their experience of waiting for heart transplant. Contradictions 
in participant’s accounts gave a sense of the challenge and evolving dynamic of 
these coping mechanisms. The contradictions in Ryan’s quote highlighted this:  
“I try not to think back to when I was working I just think of .. the 
present time now and what I'm capable of now […] (long pause) I 
suppose that makes it even more difficult because … things you could 
do four five weeks ago .. you do the same thing and you think … I 
managed this better or I managed this more four or five weeks ago .. 
so you try and push to get the same thing and you just .. don’t quite 
make it and that makes you frustrated … and then the more 
frustrated you get the more sorta ..ohhh-och! hate this .. why .. why 
me ... why did I have this heart attack … what .. what did I do to 
make me have this heart attack (pause) and you think back (sighs) I 
didn’t do anything it was just it just ... it just happened (trails off)” 
(Ryan) 
Despite his stated wish to focus on the present, Ryan ultimately ended up 
ruminating on his past abilities. This made him acutely aware of his declining 
health and his attempts to “push to get the same thing” further highlighted what 
could no longer be achieved, causing frustration and sadness. Agonisingly, Ryan’s 
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attempts to cope with distress seemed to increase his experience of negative 
emotions.  
Similarly, Michael tried to stay aligned to his sense of self, but seemed to have 
adjusted what he considered acceptable and allowed himself to take longer to 
complete tasks:  
“Personally, I can’t sit by and watch things. I've been active all my 
life I've always worked .. when I see things being done in my own 
place I want to jump in and do things .. probably a job that'll take me 
two hours will take me two days but I still try and potter about and 
do things so I'm in a very fortunate position” (Michael) 
Michael acknowledged that to feel like himself he needed activity, and 
referenced his past active self. Adjusting his expectations of what he could 
achieve may have allowed him to maintain congruence with this previous 
“active” self. He framed his experience in a positive light and there was an 
evident lack of distress both here and across his entire narrative, suggesting this 
strategy may have been a helpful way of coping.  
Alec found benefits to his waiting experience, which also alluded to regaining 
congruence with his sense of self:  
“I take pride in being the guy who needs a transplant [...] it’s given 
me opportunities to do things I’ve never done before .. all of that is 
positive things that I've taken on board and gained confidence from 
and I’ve gained that mentality [...] I feel like it’s inner strength” 
(Alec) 
Alec made numerous references to his strengths throughout his narrative and 
expressed “pride” at the way he was able to cope with waiting for a transplant, 
which showed his “inner strength”. He seemed to have found meaning in waiting 
and this helped him to feel strong. However, his mood dropped when he talked 
about his chances of surviving transplant and it was apparent he had no 
strategies to reconcile this: 
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“there’s nothing that will clear the problem there’s nothing that will 
tackle the things in your head to make them go away nothing will … 
and that’s upsetting” (Alec) 
Here, Alec seemed overwhelmed by his powerlessness which contrasted with his 
“inner strength” and it’s possible that in his wait for transplant he fluctuates 
between feeling strong and his sense of helplessness when faced with 
overwhelming uncertainty. 
Both Christopher and Andy spoke of goals and purpose. Christopher explained: 
“Once you go on the heart transplant list you feel there's now a sense 
of purpose … you feel there's an end game, you're not sure where the 
finishing line is” 
And later: 
“I'm working towards the finishing line and I'm gonna get this done” 
(Christopher) 
Christopher found a renewed sense of purpose in being listed for transplant. His 
language “end game” and “finishing line” portrayed someone coming to end of a 
battle or race, suggesting his renewed purpose had given him hope.  
Andy also described a new-found purpose – to survive for his granddaughter: 
“I don’t want to die .. I don’t want to die you know .. there are so 
many things I mean I got my first grandchild three months ago .. you 
know and ok I've come to the conclusion I’m not going to see her 
married sorta thing like but I do want to see her going to school I do 
want to be involved for a certain amount of her life and it’s a matter 
of making sure you’re there” (Andy) 
His repetition highlighted his determination to survive yet he was pragmatic 
about his shortened life expectancy, which illustrated the complex balancing act 
the men faced in their attempts to cope. There was a need to maintain hope and 
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purpose but this was restricted to the realms of rational reality. His 
determination “to make sure you’re there” seemed to filter into all aspects of 
his life and shaped his daily behaviour. Andy was convinced he would not receive 
a transplant and thus took on the responsibility to survive without it: 
“it’s about keeping yourself healthy so you don’t actually need the 
heart transplant so I can stay at the level I am now” (Andy) 
And later: 
“if I can keep the same sort of health level that I’m at just now .. 
even though I’m on the list I won’t need it” (Andy) 
Andy had set himself the challenge to maintain his current health in the face of 
a progressing illness. Andy’s past career had involved life threatening 
challenges, and it’s possible that setting himself this challenge helped him to 
find meaning and motivated further coping. 
Gregor on the other hand explained his struggle to find the benefits to his wait: 
“You've just got to try and think about the positive things and 
hopefully at the end you're going to come through […] but as I say it 
isn't easy because there's a big bit of negativity there”  
And later: 
“When you've been through so many negatives over the last twenty 
years of your life .. you don't see any light at the end of the tunnel 
[…] you just think do you know what .. it’s just not gonna happen for 
me […]”  
And later: 
“I feel that everything is going to go wrong” (Gregor) 
A long history of ill health and history of unsuccessful transplants seemed to 
have shaped Gregor’s beliefs about the success of transplant and reduced his 
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ability to remain hopeful. 
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DISCUSSION 
This study examined the lived experience of men on the routine heart transplant 
waiting list. Mens’ accounts of their experiences were analysed using IPA and 
this process resulted in three major themes:1) Threatened self identity, 2) 
Uncertain life or death, 3) Complex coping, and four interrelated subthemes. 
Deep and rich insights into the complexities of life on the heart transplant 
waiting list have been garnered and are now discussed with reference to the 
extant theory and literature.  
Threatened self identity 
Identity formation is an active process shaped by a person’s interaction with 
their environment (Hammack, 2008). Mens’ experience of waiting for heart 
transplant involved numerous threats to this process. This involved the loss of 
valued roles and aspects of life alongside the development of an unwanted 
illness identity. Both seemed partially driven by the life limitations of living with 
advanced heart failure and the restrictions placed upon the men as part of their 
wait for heart transplant. 
The loss of role whilst waiting for transplant has been documented in a previous 
qualitative study with pre and post heart transplant candidates (Poole et al., 
2016). In patients with a chronic illness the loss of valued attributes and social 
roles gave rise to a ‘loss of self’ (Charmaz, 1983). In addition, these findings 
highlighted the importance of occupation. Occupation is crucial aspect of 
identity (Laliberte‐Rudman, 2002) and the men’s narrative described how the 
loss of this led to a diminished sense of self. The development of an illness 
identity is supported elsewhere in qualitative research, including in chronic 
heart failure (Welstand, Carson, & Rutherford, 2009), chronic pain (Smith & 
Osborn, 2007) and chronic fatigue (Dickson, Knussen, & Flowers, 2008). It has 
also been described by candidates awaiting liver transplant “That’s not who I 
am, that’s not who I have been and who I know” (Brown, Sorrell, McClaren, & 
Creswell, 2006, Pg. 126). This study found that men perceived illness as a threat 
of becoming lazy or a burden. This may be partly due to societal expectations 
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placed on men to be self-sufficient and strong (West & Zimmerman, 1987). This 
illness threat to masculine identity have been reported in chronic illness and in 
older adults with advanced heart failure (Aldred, Gott, & Gariballa, 2005; 
Charmaz, 1994). 
Uncertain life or death 
The wait for heart transplant involves living and coping with a perpetuating 
uncertainty around death. Dying, either before or during transplant, 
predominated many of the mens’ accounts, and little was heard of their hopes 
for transplant. These findings suggest that pre-transplant, heart transplant is not 
necessarily perceived as the ‘gift of life’ often portrayed (Buldukoglu et al., 
2005; Lamanna, 1997). Interviews with young adults post-transplant have found 
that the ‘gift of life’ narrative sets unrealistic expectations of life post 
transplant (Waldron, Malpus, Shearing, Sanchez, & Murray, 2017), suggesting 
that this societal narrative does not reflect people’s experiences either before 
or after transplant.  
Mens’ accounts of their chances of dying may reflect the shift towards 
collaborative medical care and promotion of ‘shared decision making’ (Charles, 
Gafni, & Whelan, 1997), whereby participants are fully informed of the risks and 
benefits before agreeing to medical treatment. All men recalled the statistics 
regarding mortality and life expectancy, suggesting that this information had 
been a salient and likely frightening experience. Many acknowledged the risks 
involved and prepared for death. Some feared that their death would cause their 
family anguish and seemed unable to move past these thoughts whilst some 
appeared to discuss strategies for coping with the fear of death. This may be 
evidence of emotion focussed coping, theorised to regulate distress in 
uncontrollable situations (Lazarus & Folkman, 1987). The strategies appeared to 
include: relinquishing personal control and placing trust in another – whether 
spiritually (Albaugh, 2003) or through doctors (Hillen, de Haes, & Smets, 2011); 
or re-framing death as positive for their family. 
When men’s accounts alluded to life after transplant, this was discussed with 
trepidation. This is in contrast to findings from kidney transplant candidates, 
who described transplant as an opportunity to regain a normal life (Tong et al., 
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2015). Uncertainty about the future is common in those living with advanced 
heart failure (Europe & Tyni-Lenne, 2004) and perhaps represents recognition 
that the advanced heart failure can be fatal. Some men questioned being on the 
heart transplant waiting list, consistent with people’s experience of awaiting a 
liver or kidney transplant (Brown et al., 2006; Jonsén, Athlin, & Suhr, 2000; 
Moran, Scott, & Darbyshire, 2009) 
Complex coping 
Mens’ accounts suggested they were able to draw on a varied number of 
personal resources in order to cope with their life-threatening wait for 
transplant. Pertinent in many narratives was the importance of finding meaning. 
Meaning focussed coping is a component of the revised transactional model of 
stress and coping (Folkman, 1997) and involves drawing on beliefs, values and 
one’s purpose in life as a coping strategy when a stressor remains irresolvable 
over time. Aspects of meaning focussed coping such as finding benefits and 
adapting goals (Folkman & Moskowitz, 2007) appeared relevant in many of the 
mens’ accounts and is consistent with the previous finding that patients can 
report personal growth from their experience of illness (Cordova, Cunningham, 
Carlson, & Andrykowski, 2001). Meaning focussed coping is considered important 
in serious illness as it produces positive emotions, which provides a psychological 
break from the ongoing threat of illness and restores motivation to cope 
(Fredrickson, 1998). Negative emotions associated with the threat of transplant 
may intertwine with the positive emotions from meaning focussed coping, which 
may account for the contradictions in mens’ narratives – such as Alec’s 
conflicting pride and guilt. In a meta-analytic study, benefit finding was related 
to more positive well-being but also led to more intrusive and avoidant thoughts 
about the stressor (Helgeson, Reynolds, & Tomich, 2006). These complex 
processes were mirrored in several of the men’s accounts. 
Meaning focussed coping requires relinquishing past goals, yet some men 
appeared focussed on their pre illness abilities and they continued to set their 
expectations accordingly. This attempt to ‘continue life as normal’ could equally 
be seen as an attempt to cope and has been found among those living with other 
chronic illnesses (Dickson et al., 2008; Smith & Osborn, 2007; Spendelow, 
Joubert, Lee, & Fairhurst, 2017). This could be considered ‘denial’ - an emotion 
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focussed coping strategy aimed at regulating negative affect (Lazarus & 
Folkman, 1987). Equally, adjustment processes may be complicated by the 
“suspended animation” of the wait for transplant, whereby at any moment heart 
transplant may allow the participants a return to ‘normality’, rendering 
adjustment unnecessary (Spiers & Smith, 2016). 
Clinical Implications 
These study findings illuminate several important implications for health 
professionals working with patients awaiting heart transplantation. Firstly, the 
impact of lost occupation on identity and self-worth is an important finding, as 
many patients were encouraged to discontinue working once listed for 
transplant. A recent cross-sectional study found that time off work pre-heart 
transplant was significantly associated with a longer return to work post-
transplant (Thomson, Maddison & Sharp, in press). Supporting patients to 
continue with work should they wish or access meaningful occupation may be an 
important element of their health care. Furthermore, work places should 
consider reasonable adjustments in order to assist heart transplant candidates to 
remain in work.  
Secondly, the findings give weight to the importance of working psychologically 
with heart transplant candidates. Findings that some mens’ attempts to cope 
increased their experience of negative emotions suggests that guided discovery, 
a technique frequently used by psychologists, could be used to assist patients to 
break perpetuating cycles of ineffective coping. Additionally, acceptance and 
commitment therapy (ACT) might be of benefit to some. Acceptance and 
commitment therapy seeks to foster a person’s acceptance of their distressing 
experiences and help them find ways to live in accordance with their values, 
despite illness. This approach may help the patient access meaning focussed 
coping at times when they are overwhelmed by their situation. A recent 
systematic review of patients with long-term health conditions found that ACT 
reduced distress, and improved the ability to stay focussed in the present 
moment and engage in behaviours connected to valued life goals (Graham, 
Gouick, Krahé, & Gillanders, 2016). 
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Finally, provision of psychological care for people with physical health conditions 
is increasingly on the political agenda (Scottish Government, 2016) with 
governments increasingly aware of the need for parity between physical and 
mental health. The findings from the present study suggest it is pertinent to 
consider psychological as well as the physical elements of illness. Provision of 
emotional support is a recognised role for all health care professionals and 
guidance for brief ‘bedside’ care has been documented (Griffith & Gaby, 2005). 
It notes the importance of witnessing, validating and normalising patients 
personal experience of illness.  
Strengths and limitations 
A strength of this study is the recruitment of participants during the actual wait 
period. In previous studies, participants’ retrospective accounts may have been 
influenced by how they fared after transplant (Poole et al., 2016; Waldron et 
al., 2017), whereas this study aimed to capture patients’ lived experiences in 
the here and now. This research has focussed solely on men’s experience of 
waiting for transplant. The context of gender has likely shaped the experiences 
and interpretations reported here. It would be interesting to conduct a similar 
study with women waiting for transplant. There are several limitations to this 
study. Firstly, key contextual factors such as age, developmental stage, 
occupation and length of wait for transplant were removed to preserve 
participants’ confidentially. Such contextual factors have undoubtedly shaped 
how the men have experienced their wait for heart transplant and omission of 
these factors has reduced the depth of the interpretation presented here.  
Secondly, when participants showed distress or changed topic when discussing an 
emotive subject, the researcher did not probe for more information in line with 
ethical agreements. This may have limited a full exploration of their emotional 
experiences.  
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CONCLUSION 
The men described numerous challenges in their wait for heart transplant. These 
included threats to their identity and a tormenting uncertainty regarding the 
transplant and their survival. Many men had found ways to regain meaning, 
purpose and motivation, yet at times the emotions of the situation were 
overwhelming. There is a need for health care professionals to appreciate and 
validate the individual meaning patients ascribe to their experiences. 
Psychological interventions, such as guided discovery and Acceptance and 
Commitment Therapy may enhance a person’s coping experience.  
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APPENDICES 
Appendix 1a: Journal of Psychosomatic research guidelines for authors 
Submissions  
The Journal of Psychosomatic Research utilizes a web-based submission and peer review 
system. Authors should submit their manuscripts, with figures and tables, electronically at 
the journal Web site:https://www.evise.com/profile/api/navigate/JPSYCHORES. Complete 
instructions are available on the Web site. 
The journal reviews all material that it receives. Approximately 50% of manuscripts are 
rejected after pre-review by an editor, typically after consultation with another member of 
the editorial staff or an external peer reviewer. This is done so as to allow authors whose 
manuscripts would almost certainly be rejected after peer review to submit the work 
elsewhere with as little delay as possible. Common reasons for rejection at this stage are 
insufficient originality, low priority of interest to the journal and clear quality deficits. We 
attempt to reach an initial decision on all articles that go through full peer review within 90 
days of submission. Approximately 25% of submitted manuscripts are ultimately accepted 
for publication. 
 
 
Manuscripts should conform to the uniform requirements known as the 'Vancouver style' 
(International Committee of Medical Journal Editors. Uniform requirements for 
manuscripts submitted to biomedical journals. N Engl J Med 1997; 336:309-315). The 
Editors and Referees attach considerable importance to a succinct and lucid prose style and 
well organized tables. Authors whose native language is not English are advised to seek 
help before submission. Statistical procedures should be clearly explained.  
NEW SUBMISSIONS  
 
Submission to this journal proceeds totally online and you will be guided stepwise through 
the creation and uploading of your files. The system automatically converts your files to a 
single PDF file, which is used in the peer-review process. 
As part of the Your Paper Your Way service, you may choose to submit your manuscript 
as a single file to be used in the refereeing process. This can be a PDF file or a Word 
document, in any format or lay-out that can be used by referees to evaluate your 
manuscript. It should contain high enough quality figures for refereeing. If you prefer to do 
so, you may still provide all or some of the source files at the initial submission. Please 
note that individual figure files larger than 10 MB must be uploaded separately. 
References  
There are no strict requirements on reference formatting at submission. References can be 
in any style or format as long as the style is consistent. Where applicable, author(s) 
name(s), journal title/book title, chapter title/article title, year of publication, volume 
number/book chapter and the pagination must be present. Use of DOI is highly 
encouraged. The reference style used by the journal will be applied to the accepted article 
by Elsevier at the proof stage. Note that missing data will be highlighted at proof stage for 
the author to correct. 
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Formatting requirements  
There are no strict formatting requirements but all manuscripts must contain the essential 
elements needed to convey your manuscript, for example Abstract, Keywords, 
Introduction, Materials and Methods, Results, Conclusions, Artwork and Tables with 
Captions. 
If your article includes any Videos and/or other Supplementary material, this should be 
included in your initial submission for peer review purposes. 
Divide the article into clearly defined sections. 
Figures and tables embedded in text  
Please ensure the figures and the tables included in the single file are placed next to the 
relevant text in the manuscript, rather than at the bottom or the top of the file. The 
corresponding caption should be placed directly below the figure or table. 
Peer review  
 
This journal operates a single blind review process. All contributions will be initially 
assessed by the editor for suitability for the journal. Papers deemed suitable are then 
typically sent to a minimum of two independent expert reviewers to assess the scientific 
quality of the paper. The Editor is responsible for the final decision regarding acceptance 
or rejection of articles. The Editor's decision is final. More information on types of peer 
review. 
69 
 
70 
 
Appendix 1b: IPQ, IPQ-R and B-IPQ dimensions and example questions 
IPQ subscales Representation Questionnaire example Higher scores relate to a stronger perception that…
Cause Cause Cognitive 
Consequence CONS Cognitive "my illness has major consequences on my life" HF will have greater consequences
Control/cure C/C Cognitive "there is little that can be done to improve my illness"
Identity ID Cognitive "breathlessness/fatigue etc is related to my illness" HF has more symptoms
Timeline TL Cognitive "my illness will last a long time" HF will last a long time as opposed to a short time
Cause Cause Cognitive 
Consequence CONS Cognitive "my illness has major consequences on my life" HF will have greater consequences
Personal control PC Cognitive "what i do can determine if my illness gets better or worse" they will have greater control over the HF
Treatment control TC Cognitive "my treatment will be effective in curing my illness" treatments will be effective in managing the HF
Identity ID Cognitive "breathlessness/fatigue etc is related to my illness" HF has more symptoms
Timeline acute/chronic TLAC Cognitive "my illness will last a long time" HF will last a long time as opposed to a short time
Time cyclical TLC Cognitive 
"the symptoms of my illness change a great deal from day to 
day" HF will be cyclical
Illness coherence IC Meta-cognition "My illness doesn't make any sense to me" HF makes sense
Emotional representations ER Emotional "when i think about my illness i get upset" HF makes them emotionaly distressed.
Cause Cause Cognitive 
Consequence CONS Cognitive How much does your illness affect your life? HF will have greater consequences
Personal Control PC Cognitive How much control do you feel you have over your illness? they will have greater control over the HF
Treatment Contol TC Cognitive How much do you think your treatment can help your illness? treatments will be effective in managing the HF
Identity ID Cognitive How much do you experience symptoms from your illness? HF has more symptoms
Timeline TL Cognitive How long do you think your illness will continue? HF will last a long time as opposed to a short time
Illness coherence IC Meta-cognition How well do you feel you understand your illness? HF makes sense
Illness Concern Con
Emotional + 
cognitive How concerned are you about your illness?
Emotional Representation ER Emotional How much does your illness affect you emotionally? HF makes them emotionaly distressed.
IPQ-R subscales 
Brief illness perception questionnaire  (0-10 likert scale)
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Appendix 1c: Search strategy  
Searches conducted 12.4.18 
Database: Ovid MEDLINE(R) ALL <1946 to April 11, 2018> = 1059 
Search Strategy: 
1     ADAPTATION, PSYCHOLOGICAL/ (86692) 
2     Health Knowledge, Attitudes, Practice/ (95131) 
3     Illness Behavior/ (875) 
4     ((illness* or disease* or condition* or health) adj4 (representation* or perception* or cognition* 
or belief*)).mp. (27764) 
5     (common sense or CSM or self regulat* or leventhal).mp. (15825) 
6     Heart Failure/ (104065)  
7     ((heart or cardiac) adj failure).mp. (184920) 
8     ventricular dysfunction.mp. (40224) 
9     (HF or CHF).mp. (48752) 
10     1 or 2 or 3 or 4 or 5 (217048) 
11     6 or 7 or 8 or 9 (232838) 
12     10 and 11 (1119) 
13     limit 12 to english language (1064) 
14     limit 13 to yr="1980 -Current" (1059) 
 
Database: Embase <1974 to 2018 April 11> = 1700 
Search Strategy: 
1     psychological aspect/ (476210) 
2     health belief/ (8898) 
3     attitude to illness/ (4652) 
4     ((illness* or disease* or condition* or health) adj4 (representation* or perception* or cognition* 
or belief*)).mp. (42431) 
5     (common sense or CSM or self regulat* or leventhal).mp. (19264) 
6     heart failure/ (204516) 
7     ((heart or cardiac) adj failure).mp. (344194) 
8     ventricular dysfunction.mp. (23831) 
9     (HF or CHF).mp. (83822) 
10     1 or 2 or 3 or 4 or 5 (534675) 
11     6 or 7 or 8 or 9 (387651) 
12     10 and 11 (1909) 
13     limit 12 to english language (1706) 
14     limit 13 to yr="1980 -Current" (1700) 
 
Ebsco host CINAHL plus with full text = 250 
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Ebsco host psychINFO = 659 
 
S15  
S12 AND S13  Limiters - Published Date: 1980-2018; Language: English 
 
S14 S12 AND S13  
S13 S6 OR S7 OR S8 OR S9 OR S10 OR S11  
S12 S1 OR S2 OR S3 OR S4 OR S5  
S11 TI CHF OR AB CHF OR KW CHF  
S10 TI HF OR AB HF OR KW HF  
S9 TI ventricular dysfunction OR AB ventricular dysfunction OR KW ventricular dysfunction  
S8 TI cardiac failure OR AB cardiac failure OR KW cardiac failure  
S7 TI heart failure OR AB heart failure OR KW heart failure  
S6 DE "Heart Disorders"  
S5 TI ( (common sense or CSM or self regulat* or leventhal) ) OR AB ( (common sense or CSM or self 
regulat* or leventhal) ) OR KW ( (common sense or CSM or self regulat* or leventhal) )  
S4 TI ( ((illness* or disease* or condition* or health) N4 (representation* or perception* or cognition* or 
belief*)) ) OR AB ( ((illness* or disease* or condition* or health) N4 (representation* or perception* or 
cognition* or belief*)) ) OR KW ( ((illness* or disease* or condition* or health) N4 (representation* or 
perception* or cognition* or belief*)) )  
S3 DE "Physical Illness (Attitudes Toward)"  
S2 DE "Client Attitudes"  
Search 
Options Actions 
S14 S11 AND S12 Limiters: Published Date 1980-2018; English Language 
S13 S11  AND S12 
S12 S6 OR S7 OR S8 OR S9 OR S10 
S11 S1 OR S2 OR S3 OR S4 OR S5  
S10 TI ( (HF or CHF) ) OR AB ( (HF or CHF) )  
S9 TI ventricular dysfunction OR AB ventricular dysfunction  
S8 TI cardiac failure OR AB cardiac failure  
S7 TI heart failure OR AB heart failure  
S6 (MH "Heart Failure")  
S5 TI ( (common sense or CSM or self regulat* or leventhal) ) OR AB ( (common sense or CSM or 
self regulat* or leventhal). )  
S4 TI ( ((illness* or disease* or condition* or health) N4 (representation* or perception* or cognition* 
or belief*)) ) OR AB ( ((illness* or disease* or condition* or health) N4 (representation* or 
perception* or cognition* or belief*)) )  
S3 (MH "Attitude to Illness")  
S2 (MH "Health Beliefs")  
S1 (MH "Psychosocial Aspects of Illness")  
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S1 DE "Health Care Psychology"  
Web of Science Core Collection 885 
 
# 10 885 (#9) AND LANGUAGE: (English) 
Timespan=1980-2018 
# 9 911 #8 AND #7 
 
# 8 381,212 #6 OR #5 
 
# 7 160,231 #4 OR #3 OR #2 OR #1 
 
# 6 112,316 TS=(HF or CHF) OR TI=(HF or CHF) 
 
# 5 294,313 TS= (heart failure OR cardiac failure OR ventricular dysfunction) OR TI=(heart 
failure OR cardiac failure OR ventricular dysfunction) 
 
# 4 14,731 TI=(common sense or CSM or self regulat* or leventhal) 
 
# 3 123,032 TS=(common sense or CSM or self regulat* or leventhal) 
 
# 2 10,471 TI=((illness* or disease* or condition* or health) NEAR/4 (representation* or 
perception* or cognition* or belief*)) 
 
# 1 38,185 TS=((illness* or disease* or condition* or health) NEAR/4 (representation* or 
perception* or cognition* or belief*)) 
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Appendix 1d: Adapted AXIS tool for quality assessment 
    Yes No 
Partially Don’t know/ 
comment 
Introduction        
QR 1 Were the aims/objectives of the study clear?         
Methods        
SD 2 Was the sample size justified?         
QR 3 
Was the target/reference population clearly 
defined? (Is it clear who the research was about?)  
       
SD 4 
Was the sample frame taken from an appropriate 
population base so that it closely represented the 
target/reference population under investigation?  
    
 
  
B 5 
Was the selection process likely to select 
participants that were representative of the 
target population under investigation?  
    
 
  
B 6 
Were measures undertaken to address and 
categorise non-responders?  
       
SD 7 
Were the outcome measures used appropriate to 
the aims of the study? 
    
B 8 
Were the outcome variables measured correctly 
using instruments/measurements that had been 
trialled, piloted or published previously? (valid 
and reliable) 
    
 
  
QR 9 
Is it clear what was used to determined statistical 
significance and/or precision estimates? (eg, p 
values, CIs)  
    
 
  
QR 10 
Were the methods (including statistical methods) 
sufficiently described to enable them to be 
repeated?  
    
 
  
Results        
QR 11 Were the basic data adequately described?         
B 12 
Does the response rate raise concerns about non-
response bias?  
       
B 13 
If appropriate, was information about non-
responders described?  
       
QR 14 
Were the results for the analyses described in the 
methods, presented?  
       
B 15 
Were key potential confounding variables 
statistically adjusted for (regression only). 
    
B 16 
cohort 
Does the number of participants lost to follow up 
raise concern? 
    
B 17 
cohort 
If appropriate, was comparison made between 
full participants and those lost to follow up? 
    
Discussion        
SD 18 
Were the authors’ discussions and conclusions 
justified by the results?  
       
QR 19 Were the limitations of the study discussed?         
IPQ Specific Questions        
 20 
Was the selected Illness Perceptions instrument 
administered as designed and in line with 
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developer’s instructions? 
 21 
Were IPQ dimensions and their correlations 
reported on? 
       
KEY: QR: Items measuring quality reporting; SD: items measuring study design: 
B: Items measuring bias; Italics: adjusted or added questions from original AXIS 
tool. 
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Appendix 1e. Final quality assessment ratings agreed by primary and secondary rater. 
  
Quality of reporting Study design Bias IPQ bias 
Longitudinal 
bias 
  1 3 8 9 10 11 14 19 2 4 7 18 5 6 12 13 15 20 21 16 17 
Cross Sectional                                            
Cherrington et 
al, 2006. USA. 
Y Y Y Y Y Y Y Y N Y Y Y Y N P N N/A Y Y     
Giardini et al, 
2017. Italy. 
Y Y P Y Y Y Y Y N N Y Y N N N N P Y Y     
Hallas et al, 
2011. UK. 
Y P Y Y Y Y Y Y N Y Y Y N N Y N Y Y Y     
MacInnes 2013. 
UK. 
Y P P Y P Y P Y Y Y N Y Y N Y N N P P     
Molloy et al, 
2009. UK. 
Y Y Y N P Y Y Y N Y Y Y P Y Y Y N Y N     
Morgan et al, 
2014. IRELAND 
Y Y Y P P Y P Y N Y Y Y Y N N N Y Y Y     
Timmermans et 
al, 2017. Europe 
Y Y Y Y Y Y Y P N Y Y Y ? N ? N Y N N     
Turrise, 2014. 
(USA) 
Y N P N N Y P Y Y P Y N P N ? N N Y P     
Prospective 
Cohort 
                                          
Goodman et al. 
2013. UK 
Y Y P Y N P P Y N P Y Y P P Y Y N Y N N Y 
Mulligan et al. 
2012. UK 
Y Y Y Y Y Y P Y N Y Y Y Y Y P Y Y Y P P N 
Wierenga, 2018. 
(USA) 
P P P N N Y P P N ? N N ? P ? P Y N N ? ? 
KEY: Y= YES; N= NO; P= PARTIALLLY; N/A not applicable.          
 IPQ bias; Bias specific to use of IPQ. Longitudinal bias; bias specific to longitudinal designs. 
  Reverse score: YES is negative; NO is positive.          
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Appendix 1f: Quality assessment full results by primary and secondary reviewer 
1 3 8 9 10 11 14 19 2 4 7 18 5 6 12 13 15 20 21 16 17
Cross Sectional 
Cherrington et al, 
2006. USA.
Y Y/P Y Y P Y/P Y Y/P N Y Y Y/P Y N P N N/A Y Y
Giardini et al, 2017. 
Italy.
Y Y P Y Y Y Y Y/P N P/N Y Y/P P/N N N/P N P/N Y Y
Hallas et al, 2011. 
UK.
Y P Y Y Y/P Y Y Y/P N Y Y Y P/N N Y N/P Y Y Y
MacInnes 2013. UK. Y P P/Y Y P Y P/Y Y Y Y N/Y Y Y/P N Y N N P P
Molloy et al, 2009. 
UK.
Y Y/P Y Y/N P/N Y Y Y N Y Y Y P Y Y Y N Y N
Morgan et al, 2014. 
IRELAND
Y Y/P Y P P Y/P P Y N Y Y Y/P Y N N/P N Y Y Y
Timmermans et al, 
2017. Europe
Y Y Y Y Y Y Y P/Y N Y Y Y ?/P N ?/N N Y N N
Turrise, 2014. (USA) Y N/Y P N N/P Y/P P Y Y P/Y Y N/Y P N ? N N Y P
Prospective Cohort
Goodman et al. 
2013. UK
Y Y/P P Y N N/Y P Y/P N P Y Y P P Y Y N Y N N/Y Y
Mulligan et al. 2012. 
UK
Y Y Y Y Y/P Y/P P/Y Y N Y Y Y Y/P Y P Y Y Y P P N
Wierenga, 2018. 
(USA)
P P P N N Y P P N ? N N ? P ? P Y N N ? ?
KEY: Y= YES; N= NO; P= PARTIALLLY; N/A not applicable. 
IPQ bias; Bias specific to use of IPQ. Longitudinal bias; bias specific to longitudinal designs.
Reverse score: YES is negative; NO is positive.
Quality ratings changed to that of second rater
BOLD: direct yes/no discrepancies between primary and secondary rater
Longitudinal 
bias
Quality of reporting Study design Bias IPQ bias
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Resolution of direct Yes/No discrepancies from quality ratings: 
 
MacInnes 
(2013) 
Q7) Were the outcome measures used appropriate to the aims of the 
study? 
Discussed the primary reviewer’s findings that self-care tool lacked 
validity. Both agreed outcome measure was not appropriate because of 
this. Agreed to keep rating as “no”.  
Molloy 
(2009) 
Q9) Was it clear what was used to determine statistical significance (e.g 
P values)? 
Discussed that whilst P values given in results, P value was not stated in 
the methods section. Primary and secondary reviewer had searched for 
evidence in different sections of the article. As question appears in the 
methods section of quality assessment tool, agreed that would only score 
“yes” if this is stated in methods section. Agreed to change rating to 
“no”. 
Turrise 
(2014)  
Q3) Was the target population clearly defined? (Is it clear who the 
research was about? 
Discussed that “chronic” heart failure had not been operationalised and 
illness severity determined by NYHA not provided. Agreed to keep rating 
as “no”. 
 Q18) Were the authors discussions and conclusions justified by the 
results? 
Reviewer highlighted areas thought to be overstated conclusions in light 
of the results. Second reviewer agreed. Rating kept as “no”. 
Goodman 
et al. 
(2013):  
 
Q11) Were the basic data adequately described? 
Discussed that basic demographics did not add up to 100% and therefore a 
“no” rating should be given. Second-rater had not seen this. Agreed to 
change rating to “partially”. 
 Q16) Does the number of participants lost to follow up raise concern? 
Discussed that whilst numbers lost to follow up, primary reviewer 
highlighted that no statistical difference was found between those 
included in analysis and those lost to follow up. Agreed to keep rating as 
“no”.  
 
 
 
 
Appendix 2a:  Author submission guidelines to the Journal of Heart and 
Lung Transplant 
Aims and scope 
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CONSENT FORM (Version 2.1 27.6.17) 
 
Study: Experiences, beliefs and coping whilst waiting for heart transplant: An 
interpretative phenomenological study. 
Researcher: Rebecca Jury  
 
Please initial the box to indicate you have read and agreed.  
I have read the participant information sheet (version 2.1, 27.6.17) 
 
 
I have had the chance to consider the information and ask questions. 
 
 
My questions have been answered satisfactorily. 
 
 
I give permission for my interview to be recorded. 
 
 
I understand that my participation is voluntary and that I can stop the interview at any time, 
without giving a reason and without my medical care being affected. 
 
I understand that my interview will be transcribed by Rebecca and that my anonymous 
transcript may be looked at by Rebecca’s research supervisors as part of the data analysis 
 
I consent to Rebecca posting or emailing me a copy of the initial themes she identifies. 
 
 
I understand that the study sponsor- NHS Greater Glasgow and Clyde- may request to look at 
my personal information to make sure the study is being conducted correctly and to ensure 
that data is not being fabricated. 
 
I agree that comments from my interview can be used in the final report,  
presentations and publications. All names, places and any patient identifiable information will        
be removed. Nothing that identifies me will appear for others to see. 
 
I consent to Rebecca storing my contact details on a password protected  
document on a secured NHS computer for the duration of the study. 
 
I understand that my anonymous interview recording and interview transcript will  
be privately and securely stored on the University of Glasgow Enlighten research software for          
10 years, after which it will be destroyed.  
 
I agree that my GP can be informed of my involvement in the study. 
 
 
I agree to take part in this study. 
 
 
 
Subject Name: 
 
Date: Signature: 
 
 
Researcher Name: 
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PARTICIPANT INFORMATION SHEET 
 
 
Study: Experiences, beliefs and coping whilst waiting for heart transplant: An 
interpretative phenomenological study. 
Researcher: Rebecca Jury  
 
 
We would like to invite you to take part in a research study. To help you decide 
if you would like to take part, you need to understand what taking part would 
involve for you. Please take your time and read the following information 
carefully.  
Who is conducting the research?  
The research is being carried out by Ms Rebecca Jury who is a Clinical 
Psychologist in training at the University of Glasgow. The research is being 
supervised by Dr Sarah Wilson from the University of Glasgow, and Dr John Sharp 
from the National Advanced Heart Failure Service. Rebecca does not work at the 
Golden Jubilee Hospital, but she does have an interest in psychology and cardiac 
health. 
Why are we doing this research?  
We know that it can be a long wait from when a person is told they need a heart 
transplant to when they receive one. Research suggests that this wait can be a 
distressing time and that people may have to deal with lots of worries and 
concerns. People may use many different ways to try and cope. We think it 
would be useful to learn more about how this waiting time is experienced by 
people and what they do to cope. This may help health care professionals to 
better understand people’s experiences and it may help to develop support for 
people who are waiting for a heart transplant in the future 
Why have I been invited?  
 
 
We are inviting people who are currently on the routine waiting list for heart 
transplant with the Scottish National Advanced Heart Failure Service. We believe 
you fit these criteria and that is why we have invited you to take part.  
What does taking part involve? 
You will meet with Rebecca Jury to talk about your experiences of waiting for a 
heart transplant. This will include the challenges you face, your thoughts, 
concerns or worries about transplant and the ways in which you try to cope with 
waiting. This interview will take place in a comfortable, non-medical room at 
the Golden Jubilee Hospital. It will take up to 1 hour, but it may take less. You 
will be able to take a break at any time during the interview and you don’t have 
to answer any questions you don’t want to. 
Rebecca will audio record your interview so that the she can make sure she 
captures everything you say and so she can listen back to the discussion and type 
it up into a transcript. This allows Rebecca to look at the things you said during 
the interview and compare it to what others have said during their interviews. 
The idea is to look for shared themes in people’s experiences. With your 
consent, you will be posted or emailed a copy of the initial themes Rebecca 
identifies and given the opportunity to think about whether you feel these 
themes are a good representation of your experience. You will be able to email 
or telephone Rebecca to share your thoughts, which Rebecca will use to help 
when analysing the interviews. When Rebecca types up your interview, she will 
not use your real name, but use a fake name instead. She will also change any 
family names and significant place names to ensure that your interview 
transcript is anonymous. Your interview will be kept private and will not be 
shared with the Scottish National Advanced Heart Failure Service, unless you 
mention that you or someone else is at risk of harm, in which case we have a 
duty of care to share this information to ensure your, or another’s, safety.  
Do I have to take part? 
No. The decision to take part is entirely up to you.  
What happens if I decide to take part? 
If you decide to take part, you can either contact Rebecca by email or agree to 
your contact details being passed onto Rebecca and she will contact you. She 
will arrange a time to meet with you. Please let your transplant coordinator or a 
member of the Scottish National Advanced Heart Failure Service know that you 
would like to take part, and they will let Rebecca know. If you agree to take 
 
 
part, you will be asked to sign a consent form to evidence that you are happy to 
take part and that you understand what this involves. You can change your mind 
at any point and you won’t need to give a reason for this.  The care you receive 
will not be affected. We will let your GP know that you have agreed to take part 
in the study. 
What happens to my information? 
The anonymised audio recordings and any written information will be kept on an 
encrypted University of Glasgow computer and backed up onto the password 
protected network server for the duration of the research study. This 
information will be stored in accordance with the Data Protection Act, which 
means that we keep it securely and cannot reveal it to others without your 
permission. Rebecca may share your anonymised interview transcript with her 
research supervisors to ensure accurate data analysis. Sometimes, the study 
sponsor- NHS Greater Glasgow and Clyde- may want their research 
representative to look at your personal information, to make sure the study is 
being conducted correctly and to ensure that data is not being fabricated.  
When the study is complete, your audio recordings and interview transcripts will 
be transferred to University of Glasgow research software, for private and 
secure storage of research data for 10 years. At this time, all your information 
will be deleted from the encrypted laptop. After 10 years, the research data will 
also be deleted. The information from your and other people’s interviews will be 
written up into a report. Some direct quotes from your interview may be 
included in this report, but your name will be changed and nothing which 
identifies you will be included. The report will be given to the University of 
Glasgow as part of a doctoral thesis in Clinical Psychology and stored publicly on 
The University of Glasgow Library website. The report may also be submitted for 
publication in a research journal, so that other health care professionals around 
the UK can learn from the study results. If you’re interested in seeing the final 
report, Rebecca can send you this. 
What are the possible benefits of taking part? 
Your participation will help health care professionals to better understand the 
challenges experienced by people waiting for heart transplant, which in turn 
may help to develop new supports for people. It is hoped that you may find some 
benefit from having the opportunity to talk about your experiences. If you feel 
 
 
distressed during or after the interview, we will ensure that you have 
information on how to access appropriate supports, if you need to.  
Who has reviewed the study? 
To make sure the study is being conducted correctly, it has been reviewed by 
the West of Scotland Research Ethics Committee and the NHS National Waiting 
Times Board and Greater Glasgow and Clyde Research & Development 
Department.  
What if you have a complaint about any aspect of the study? 
If you are unhappy about any aspect of the study and wish to make a complaint, 
please contact the researcher in the first instance but the normal NHS complaint 
procedure is also available to you.  
If you have any further questions; 
Please contact the researchers at:  
Rebecca Jury 
Institute of Health & Wellbeing, 
University of Glasgow 
Administration Building 
1st Floor 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow G12 0XH 
Email: r.jury.1@research.gla.ac.uk 
Tel: 01412110607 
Dr Sarah Wilson 
Institute of Mental Health & 
Wellbeing, 
University of Glasgow 
Administration Building,  
1st Floor 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow G12 0XH 
Email: Sarah.Wilson@glasgow.ac.uk 
Tel:  01412113921 
 
If would like to speak to someone who is not closely involved in the study, then 
you can contact Dr Sue Turnbull. Her telephone number is: 0141 211 3900 
Thank you for taking the time to read this information sheet. 
 
I would like to take part, what shall I do now? 
• You can let Rebecca the researcher know that you would like to take part by 
email on r.jury.1@research.gla.ac.uk and she will be in touch. 
• Alternatively, please let your transplant co-ordinator, or any member of the 
Scottish National Advanced Heart Failure Service know that you would like to 
take part. 
o You can do this by telephone on: 0141 951 5472 
o You can do this by letter to:  
 
 
Scottish National Advanced Heart Failure Service 
Golden Jubilee National Hospital 
Agamemnon Street 
Clydebank G81 4DY 
o You can do this at your next appointment. 
• The team will let Rebecca know you are interested and she will ring you to 
arrange a time to conduct your interview.  
• Rebecca will be happy to answer any questions or concerns you have.  
 
 
 
 
Appendix 2e: Interview schedule 
INTERVIEW SCHEDULE (V1.2 6.6.17) 
Study: Experiences, beliefs and coping 
whilst waiting for heart transplant: An 
interpretative phenomenological study. 
Researcher: Rebecca Jury  
 
 
Introduction 
Thank you for meeting with me today. My name is Rebecca. I’m a trainee 
psychologist and I am researching people’s experience of waiting for a heart 
transplant. I’ll be asking you some questions about the challenges of waiting for 
a heart transplant, what sense you make of heart transplantation and your 
experience of coping with the wait for a heart transplant. I’m really interested 
in you and your experience of waiting for transplant. There are no right or 
wrong answers – really I just want to hear what you have to say. So I’ll be doing 
a lot of listening, and perhaps not a lot of talking. When I do ask you questions, 
it will be because I’m really trying to understand how you have experienced 
something. Sometimes you might say things I want to ask you more about, so I 
might jot it down on this paper to remind me to come back and ask you about it. 
I have a digital recorder here to record our interview. This will make sure I have 
got what you say right.  
 
I know that some things we talk about today might be upsetting to talk about. 
You can take a break at any point during the interview, just let me know. Also, 
you don’t have to answer any questions you don’t want to.  
I want you to know that I am not a member of staff here and I do not work with 
the team. What we talk about today is confidential and will not be shared with 
the team. However, if you tell me that you or someone else is at risk of harm, 
then I have a duty of care to report this to a relevant member of staff in order 
to keep you or someone else safe.  
 
Before we start we’ll go through the information sheet to see if you have any 
questions. After that I will ask you to sign a consent form, which asks whether 
you understand what is involved in taking part and whether you agree to take 
part.  [Go through participant information sheet and consent form]. 
Do you have any questions? 
Do you have any physical symptoms today that you think might make the 
interview difficult? [is there anything I can do to make your experience more 
comfortable/if you feel unwell just let me know and we can take a break or stop 
the interview].  
 
 
 
Any questions? Shall we start? 
Administrative question 
Once I have written up the interviews from all the participants, I will start to 
look for shared themes in people’s experiences.  
• Would you like me to send you a copy of initial themes so that you can consider 
if they feel like a good representation of your experience?  
• Would you like these sent by post or email? 
• Would you like copy of final report, once it is all written up? 
• Would you like this sent by post or email? 
Establishing rapport and general information 
1. I’m interested in your experience of being told that you needed a heart 
transplant, please can you tell me about that?  
P: What was that like for you? What did you make of that? How did that feel? 
Challenges of waiting for transplant 
2. My understanding is that there is a wait involved in getting a heart 
transplant, how have you experienced that waiting process?  
P: To what extent does waiting for a heart transplant affect your life?  
P: affect you emotionally? Job? Family? Physically?  
3. Please could you tell me about the hardest part of waiting for a heart 
transplant? 
4. Please could you tell me about any worries you have, about your wait 
for a heart transplant?   
Beliefs about waiting for a donor 
5. My understanding is that waiting for a heart transplant means you are 
waiting for a donor heart, I’d be interested to hear what sense you 
have made of that? 
P: What you think about receiving a donor heart? How do you feel? 
P: any worries? Affect emotionally?  
6. How do any friends or family think about you getting a donor heart?  
P: What do you make of that? How have you experienced that? What has that 
been like for you? 
7. Could you tell me what you think will be good about receiving a donor 
heart? 
Coping with waiting for heart transplant 
 
 
8. Some people talk about how they try to cope with waiting for a heart 
transplant. Is that something you can relate to? 
P: How do you think you are coping? 
9. How do others help you to cope with you wait for heart transplant?  
P: What is that like for you? 
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Appendix 2g: Sample tabulated quotations for Ryan. 
 
THREATENED IDENTITY UNCERTAIN LIFE OR DEATH COPING 
Loss of what defined me? Daily/temporal uncertainty?  Family 
"with my heart I can't do 
what I want to do .. I can't 
go for  along walk up a hill 
or take the dog for a stroll 
along the back or climb a 
mountain or anything like 
that a flight of stairs is 
enough for me .. And I want 
.. I want my life back how it 
used to be .." pg 5  
"you wake up everyday 
thinking , is this the day? 
you go to bed 'oh well that's 
another day' and you wake 
up tomorrow .. Is it gonna 
be today? and its a 
complete circle it just goes 
round and round and round 
and round" pg 15  
"everything’s sorted so she not got 
to worry about anything like that .. 
Everything’s sorted so she’s .. she 
knows everything my poor wife 
knows that if (laughs) I'd be quite 
happy that if I was climbing up the 
side of a building and I dropped 
down .. Shes knows I'd die happy" 
pg26 
" I think back to when I used 
to be at work and I love my 
work .. I used to to a lot of 
heavy lifting and I think 
back to when I'd throw a 
(sofa?) over my shoulder 
and walk up to the 
warehouse with a three 
seater setee , rolls of carpet 
and anything like that and I 
think how could I do that 
when now a couple of bags 
of shopping and I struggle" 
pg 23  
"there's not a day when I 
haven't had this 'is this 
gonna be the day' .. And 
then there's other days you 
(sighs) there's some days 
you think like that but other 
days you think (sighs) I wish 
it was today I wish it was 
now I wish it was today" pg 
20  
"Everything’s in order everything’s 
sorted out .. my wife knows every 
insurance policy our finances are 
sorted out .. it has to be as stupid 
as it sounds it has to be because if 
you get this phone call and its 
literally as case of your gone .. 
everything has to be you know to 
keep running ..[...] everything’s 
sorted so she's not go to worry 
about anything like that pg 25 26  
Someone I'm not? Future uncertainty? Accepting death? Minimising death? 
"I gotta set myself goals 
cause if I didn't set myself 
goals I'd sit there and I'd 
watch the tele till I'd 
watched every programme 
that was on the planet and 
I'm sorry but that's just not 
me ive never been one for 
sitting down and watching 
TV or anything like that I’ve 
always had to be doing 
something" pg 17 
"your head ends up 
scrambled because you start 
thinking oh I could do this 
and you think oh no I 
couldn't do this because if I 
.. Start doing this and I get 
a phonecall and then that 
happens and you think 
ahhh" pg34 
"I didn't think about the dying thing 
the dying thing the dying thing 
doesn't actually bother us because 
everybody at some points going to 
die that's settled " pg 26 
you try and do so much and 
you just and the frustration 
kicks in because you can't 
do it or your trying to do 
something that you can't do 
and you get frustrated and 
you just (sighs) I'm not a 
bad tempered person 
(laughs) I'm quite an easy 
going person" pg 33  
you think well there's all 
these statistics that they 
have .. a percentage live 
this long there's a 
percentage live that long .. 
even though I'm looking 
forward to the transplant 
(pause) I know there's still 
this (pause) still a 
percentage game of how 
long I'm gonna get out of it" 
pg 26  
If I'm cutting the grass and I drop 
down dead .. That's it .. Fair 
enough if I happen to be playing 
bowls on the bowling green and I've 
fallen that'll be it its no something 
I think about its no something I 
worry about errr everything ..  
 
 
 
Appendix 2h: Feedback from participants regarding themes.  
Participants were sent descriptions of the themes and then asked the following 
 
Which of the below statements do you agree with:  
A) I think the themes do a good job of capturing my experience of waiting for transplant  
B) I think the themes partially capture my experience of waiting for transplant  
C)  I think the themes do not really capture my experience of waiting for transplant.  
  
I would also welcome any other comments you may have below:  
 
Hi Rebecca  
 
Sorry for taking so long to reply. 
 
The answer to the question at the bottom is A 
 
I think you have done a great job of putting down on paper the majority of my thoughts and fears. 
 
I hope the project turns out to be a success and some good comes of it. 
 
 
 
Appendix 2i: Excerpt from reflexive journal 
After [XX] interview 
Struck by idea of identity shaped by meaningful purposeful life and activity. This then 
influenced how I reflected back to P2 and P4 – could see how this was relevant for their 
narratives. Thought back to P4 and realised I may have missed what was salient for his 
experience – wondered if I tried too hard to stick to schedule. Felt like I could start to see 
the bigger picture knitting narratives together – recognising that I will probably now be 
looking for this in transcripts and how supervision and coding by others will be important 
to check analysis not biased by this. Also struck by trust in others and how this interacts 
with wait.  
 
After [XX] interview 
Struck by halting of developmental trajectory.  
 
After coding [XX] 
With new reflections on the need for meaningful activity – as I was coding I could see 
there were moments where I could have probed about this but didn't as it wasn't on my 
mind during the interview – at the time of interview I was biased in my thinking by my 
experience of P1+2. So whilst now I can see that need for work is present - I didn't explore 
this as much as might have been useful.  
 
Reflecting on process of analysis to date + supervision 
From coding the first two interviews it helped me recognise that peoples core experience 
will come up throughout the narrative – helped me to see that people to repeat key 
points - this influenced how i conducted later interview. I’ve focussed more on active 
listening – I’ve noticed how participants will often guide you to what feels salient for their 
core experience regardless of questions – used schedule loosely. Importance of real 
active listening and curiosity – similar to my clinical work. For some people questions did 
not feel core to their experience – for example questions about donor hearts – not really 
relevant for some people. This experience helped me to reflect that actually were some 
of my questions biased by what I expected to find? Expected ‘anxst’ about donor heart 
and expected themes of constant distress around the uncertainty of waiting … whilst P1 
and 2 maybe adhered more to my expectations – the following participants did not which 
help me think more broadly. Reflected on how life experiences and the shaping of 
personality and coping can lead to huge variations on how wait experienced. This also 
influence how my interviews went – again trying to really tune in to what felt salient 
rather than hunt for what I expected to find. IN supervision today we reflected how, from 
my reflections about the need for occupation and meaning might point towards how 
waiting is actually experienced as loss of meaning – rather than being this experience of 
constant dread of waiting. I can see how the coding and interpretation of P3-7 will be 
influenced by this. With each transcripts I spot more elements which then mean I pay 
attention for these when doing the next transcript. Recognise I will need to go back and 
do P1+2 as well to try and counteract this bias towards more insightful interpretations for 
later transcripts only.  
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ABSTRACT  
Background 
Heart transplant is considered for people with end stage heart failure whose lives are at 
risk. It involves waiting for an unknown amount of time for a donor heart from a person 
who has recently died, during which the person may not survive. This wait can be a long 
and distressing, yet little research has explored how people experience this process. 
Such research may be important for informing intervention. 
Aims 
To explore people’s experiences of waiting for heart transplant in order to gain a better 
understanding of the challenges they encounter, their beliefs around transplant and 
their experience of coping. 
Methods 
Interpretative phenomenological analysis will be used with people 18 or over on the 
waiting list for heart transplant at the Scottish National Advanced Heart Failure Service 
(SNAHFS) who have consented to an interview regarding their experiences of waiting for 
transplant. 
Applications 
This research may allow teams to develop interventions for people waiting for heart 
transplant to decrease distress and improve quality of life during the wait period. 
Research will be circulated to SNAHFS staff and will be submitted for publication. 
 
 
INTRODUCTION 
1.1 Waiting for heart transplant in Scotland  
Heart transplantation is an established treatment for end-stage heart failure (HF) 
yet donor heart availability is below that needed, leading to a wait for transplant 
(Scottish Government, 2013). The journey to transplant is complex; initially, 
patients with HF are monitored within their local health board and only referred to 
the Scottish National Advanced Heart Failure Service (SNAHFS) when advanced 
therapies, such as heart transplantation, are indicated. Following referral, patients 
undergo extensive assessment from a multi-disciplinary team to ensure their 
suitability for transplant. If transplantation is agreed, prospective candidates are 
listed as super-urgent, urgent or routine depending on illness severity. Typically, 
those on the super urgent or urgent list are required to remain in hospital, whilst 
those routinely listed are required to wait at home.  The length of, determined by a 
range of factors including; organ availability, the need to match donor and recipient 
size and blood type, presence of antibodies, and the candidates position on the UK-
wide transplant list. In 2003 the average adult wait was 164 days (Scottish 
Government, 2003). The person must tolerate numerous stressors during this wait, 
including; worry about family, illness symptoms, waiting for a donor, uncertainty 
about the future, fatigue, less control over their lives and an increased dependency 
on others as well as the concept of losing one’s heart and accepting another from 
someone who has died (Bunzel, 2012; Jalowiec, Grady, & White-Williams, 1994). 
Anecdotally, candidates can experience hopelessness and go through periods of 
existential crisis, at times leading to increase in apprehension and anxiety. 
Psychological distress during this time is not uncommon, with the majority of 
patients scoring from the subclinical to mild range for depression and anxiety 
(Burker, Evon, Losielle, Finkel, & Mill, 2005; Deshields, McDonough, Mannen, & 
Miller, 1996). As the wait period extends, patient’s depression, physical symptoms 
and impairment in functioning can increase (Zipfel et al., 1998).  
 
1.2 Coping with the wait for heart transplantation. 
Throughout the wait period, heart transplant candidates may engage in numerous 
coping strategies, conceptualised as either problem solving strategies, which are 
attempts to alter the situation, or emotion focussed strategies, which are attempts 
to alter the emotional distress (Lazarus & Folkman, 1987). Candidates reportedly 
use both, including planning, seeking social support and trying to keep life normal as 
well as positive reinterpretation, humour use and gaining comfort from religion 
(Burker et al., 2005; Porter et al., 1994). According to the self regulation model, 
selected coping strategies can be influenced by a person’s perception of their illness 
 
 
(Leventhal, Diefenbach, & Leventhal, 1992). When candidates perceive HF as linked 
to negative consequences or a lack of control, people tend to select denial and 
disengagement (Hallas, Wray, Andreou, & Banner, 2011). This could affect their 
candidacy if they are seen as not engaging with treatment process, as well as 
increasing their risk of mortality and depression (Burker et al., 2005; Murberg & Bru, 
2001). Exploring candidate’s perceptions of their illness and coping whilst waiting 
for heart transplant may uncover a greater understanding of their needs at this 
time.  
1.3 Existing qualitative literature 
Qualitative research conducted post-transplant has largely focussed on information 
and support, finding that support during the wait period from post- transplant 
individual is perceived as positive and beneficial  (Ivarsson, Ekmehag, & Sjöberg, 
2013; Sadala & Stolf, 2008). However, the retrospective designs may be vulnerable 
to recall bias (Singer & Salovey, 1988), thus jeopardising the studies validity. 
Research conducted during the actual wait period have utilised thematic analysis 
and focus groups to explore perceived care needs (Haugh & Salyer, 2007; Yorke & 
Cameron‐Traub, 2008) or an existential phenomenological approach to explore 
candidates experience of loss  (Poole et al., 2016). These studies have all 
implemented a mixed participant group; including either lung transplant candidates; 
post-transplant recipients or family members. Therefore, the emerging themes may 
not best represent heart transplant candidates true experiences, nor uncovered the 
depth of issues discussed above.  An in depth exploration solely with heart 
transplant candidates may allow transplant teams to better understand patient 
experience and tailor interventions accordingly.   
 
2 AIMS 
This research aims to better understand the lived experience of, and the meanings 
associated with, the process of waiting for heart transplantation. This may inform 
interventions to optimise the patient experience throughout the wait period. 
The following will be explored;  
1. The challenges patients experience  
2. Patients beliefs around heart transplantation 
3. Patients experiences of coping 
3 PLAN OF INVESTIGATION 
3.1 Participants  
Individuals will be recruited from the SNAHFS heart transplant waiting list at the Golden 
Jubilee National Hospital (GJNH). The routine list comprises individuals awaiting 
transplant as outpatients, for an unknown amount of time. This differs to individuals 
 
 
listed as super urgent or urgent, who are required to wait in hospital for a potentially 
imminent transplant. Only those routinely listed will be included in order to preserve 
sample homogeneity required by IPA (Smith, Flowers, & Larkin, 2009). Additionally, 
over a four-month period only two people were identified on the super urgent and 
urgent list compared to nine-fourteen on the routine list, highlighting the routine list as 
a more suitable recruitment option. Individuals will only be recruited 3 months post 
referral for transplant, to allow for a potential 3 month adjustment period following a 
psychosocial stressor, termed an adjustment disorder (American Psychiatric Association, 
2013). 
Inclusion criteria 
o Written informed consent  
o Fluent in English 
o Aged 18 or over 
o 3 months or more since referral for heart transplant. 
o Listed on routine transplant list 
Exclusion criteria  
o Patient’s with a history of previous heart transplant.  
o Listed on super urgent or urgent transplant list 
o Learning disability 
3.2 Recruitment Procedures  
Recruitment will last throughout the study until the target sample is met. The 
transplant coordinators working at SNAHFS will identify individuals who meet the 
inclusion criteria. Transplant coordinators will inform individuals of the study during 
routine appointments or telephone calls, and provide them with the participant 
information sheet. Individuals interested in participating will have the option to 
contact the team or the researcher directly. The researcher will arrange a suitable 
time to conduct the interview. Where feasible, the person will be offered the 
opportunity to attend directly before or after a routine hospital appointment. 
Confirmation of the interview date and the participant information sheet will be 
sent by post. On the day of interview, individuals will be given the opportunity to 
ask further questions, confidentiality will be discussed and signed written consent 
gained. Participants will be recruited on a first come basis until the required number 
is met.  
3.3 Design  
To allow participants to share their unique experiences, a qualitative design will be 
used. Interpretative phenomenological analysis (IPA) was considered most 
appropriate as it was developed for use in health psychology (Smith, 2011), is suited 
to helping clinicians understand the meaning of patients lived experience (Harper, 
 
 
2011; Starks & Trinidad, 2007) and has been frequently applied to understanding 
experiences of physical illness (Smith et al., 2009). 
3.4 Research Procedures  
Face-to-face, semi structured interviews will be conducted, utilising an interview 
guide developed from three sources. Firstly, the researcher will attend a pre 
transplant clinic to glean a better understanding of patient experience,  secondly, 
through consultation with clinical psychologists working within heart transplant 
centres and thirdly, from the research literature. The interview guide will include 
questions on individual’s experiences, beliefs and coping with waiting for heart 
transplant. Further ideas will be incorporated as appropriate. Interviews will be 
conducted by the principal researcher in a GJNH room, using a digital voice recorder 
and will last up to one hour. This is not dissimilar to the time required for routine 
SNAHFS appointments and is less time than in previous IPA studies with an end stage 
HF population (Murray, Kendall, Boyd, Worth, & Benton, 2004; Murray et al., 2002; 
Rogers et al., 2002). Participants will be reminded of the purpose of the interview 
and to inform the principal researcher if they begin to feel unwell or wish to 
discontinue. 
3.5 Data storage 
Consent forms will be stored in a locked filing cabinet within NHS GJNH, and 
transferred to a locked filing cabinet at the University of Glasgow on study 
completion. Recordings will be immediately transferred to a University of Glasgow 
encrypted laptop and deleted from the digital voice recorder. Once transcribed, 
transcriptions will be stored on the laptop, with all identifiable patient information 
removed and pseudonyms provided. Back-up copies of recordings and transcripts will 
be stored within a password protected part of the Glasgow University network, only 
accessible to the principal researcher. On study completion, transcripts and 
recordings will be deleted from the laptop and network and transferred to enlighten 
for 10 years, as per the Code of Good Practice in Research (University of Glasgow, 
2016) and thereafter deleted in accordance with the Data Protection Act (London: 
Stationery Office, 1998).  
3.6 Data Analysis  
Recordings wills be anonymously transcribed. Transcripts will be analysed using IPA, 
following the six steps outlined in (Smith et al., 2009) (p.79-103); 
1. Reading and re-reading. 
2. Initial noting. 
3. Developing emergent themes. 
4. Searching for connections across emergent themes. 
5. Move to the next case. 
 
 
6. Looking for themes across cases. 
 Emerging themes will have validity confirmed through blind transcript review by 
two research supervisors and through feedback on themes from interested 
participants.   
3.8 Justification of sample size  
IPA research uses samples of between one and ten participants (Starks & Trinidad, 
2007) and four to ten is considered suitable for professional doctorate research 
(Smith et al., 2009). A four month waiting list review approximates 9-14 eligible 
patients. Past research evidences that over half of people with chronic HF uptake 
the offer to take part in qualitative research (Klindtworth et al., 2015; Mair et al., 
2011; Rogers et al., 2002), therefore the target sample is 6-10 participants.  
3.9 Settings and Equipment  
Interviews will be conducted within GJNH private rooms. A digital voice recorder, 
headphones and an encrypted laptop will be provided by the University of Glasgow. 
 
4 HEALTH AND SAFETY ISSUES  
4.1 Researcher Safety Issues  
See appendix. 
4.2 Participant Safety Issues  
See appendix. 
5 ETHICAL ISSUES  
Ethical approval will be sought from the West of Scotland Research Ethics 
committee and from NHS Research and Development at the NHS National Waiting 
Times Board. In line with the BPS code of human research ethics (British 
Psychological Society, 2014) the potential risk to participants will be managed (see 
appendix A), an information sheet will clearly communicate the research aims, 
written consent will be gained, data will be anonymised so that participants cannot 
be personally identified and a research dissemination plan agreed which will seek to 
maximise the benefits of the research. A summary of the results will be made 
available to interested participants. All data collected will remain confidential and 
stored in line with the Data Protection Act (1998), Freedom of Information Act 
(2000), and the NHS Confidentiality Code of Practice on Protecting Patient (NHS 
Scotland, 2012). 
 
6 FINANCIAL ISSUES  
Telephone calls cost will be met by SNAHFS. Administration costs will be covered by 
Glasgow University, see appendix. 
 
 
 
7 TIMETABLE 
01/17 Submit final MRP proposal to University for peer review 
05/2017 Gain NHS sponsorship 
06/2017 Apply for REC application (4-8 weeks). 
08/2017 REC approval, apply NHS R&D approval  
08/2017 Begin recruitment/ data collection  
12/17-01/18  Data transcription and analysis.  
02/18 Blind review of emerging themes.  
05/18 First MRP draft submitted 
07/18 Final MRP draft submitted 
 
8 PRATICAL APPLICATIONS  
The results will be written up as part of a Clinical Psychology professional doctoral 
thesis and the report published on Glasgow University thesis website. The research will 
be shared with interested participants, the SNAHFS team and submitted for publication. 
It may inform interventions for patients during the wait period and has the opportunity 
to directly impact on the clinical psychology services offered at the GJNH. 
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